###begin article-title 0
###xml 94 95 94 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn2">S&#8414;</xref>
Enhancer of Zeste Homologue 2 (EZH2) Down-regulates RUNX3 by Increasing Histone H3 Methylation*Sâƒž
###end article-title 0
###begin p 1
###xml 96 118 96 118 <email xmlns:xlink="http://www.w3.org/1999/xlink">aochiai@east.ncc.go.jp</email>
 To whom correspondence should be addressed. Tel.: 81-4-7134-6855; Fax: 81-4-7134-6865; E-mail: aochiai@east.ncc.go.jp.
###end p 1
###begin p 2
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 2
###begin p 3
 applies to Author Choice Articles
###end p 3
###begin p 4
###xml 249 254 249 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 298 302 298 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e.</italic>
###xml 455 460 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 566 571 566 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 749 754 749 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 776 781 776 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 861 866 861 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 884 889 884 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 1222 1229 1222 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo</italic>
###xml 1415 1420 1415 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 1462 1467 1462 1467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 1365 1373 <span type="species:ncbi:9606">patients</span>
Overexpression of enhancer of zeste homologue 2 (EZH2) occurs in various malignancies and is associated with a poor prognosis, especially because of increased cancer cell proliferation. In this study we found an inverse correlation between EZH2 and RUNX3 gene expression in five cancer cell lines, i.e. gastric, breast, prostate, colon, and pancreatic cancer cell lines. Chromatin immunoprecipitation assay showed an association between EZH2 bound to the RUNX3 gene promoter, and trimethylated histone H3 at lysine 27, and HDAC1 (histone deacetylase 1) bound to the RUNX3 gene promoter in cancer cells. RNA interference-mediated knockdown of EZH2 resulted in a decrease in H3K27 trimethylation and unbound HDAC1 and an increase in expression of the RUNX3 gene. Restoration of RUNX3 expression was not associated with any change in DNA methylation status in the RUNX3 promoter region. RUNX3 was repressed by histone deacetylation and hypermethylation of a CpG island in the promoter region and restored by trichostatin A or/and 5-aza-2'-deoxycytidine. Immunofluorescence staining confirmed restoration of expression of the RUNX3 protein after knockdown of EZH2 and its restoration resulted in decreased cell proliferation. In vivo, an inverse relationship between expression of the EZH2 and RUNX3 proteins was observed at the individual cell level in gastric cancer patients in the absence of DNA methylation in the RUNX3 promoter region. The results showed that RUNX3 is a target for repression by EZH2 and indicated an underlying mechanism of the functional role of EZH2 overexpression on cancer cell proliferation.
###end p 4
###begin p 5
###xml 27 96 27 96 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Ministry of Education, Culture, Sports, Science and Technology, Japan</grant-sponsor>
###xml 104 112 104 112 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">19590417</grant-num>
###xml 266 279 266 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">advertisement</italic>
This work was supported by Ministry of Education, Culture, Sports, Science and Technology, Japan, Grant 19590417 (to S. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 5
###begin p 6
The on-line version of this article (available at ) contains supplemental Fig. S1.
###end p 6
###begin p 7
Author's Choice - Final version full access
###end p 7
###begin p 8
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX</italic>
###xml 58 70 58 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX1, RUNX2</italic>
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 143 147 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX</italic>
###xml 319 320 319 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 358 359 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 382 383 382 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 385 386 385 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 448 449 448 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 451 452 451 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 560 565 560 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 647 648 647 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 813 818 813 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 820 821 820 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 862 867 862 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 944 949 944 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 1045 1046 1045 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 1075 1076 1075 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 1094 1096 1094 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 1113 1115 1113 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 1137 1139 1137 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1160 1162 1160 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1182 1184 1182 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 1209 1211 1209 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 1220 1225 1220 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 1331 1336 1331 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
Three members of the Runt-related (RUNX) family of genes, RUNX1, RUNX2, and RUNX3, play pivotal roles in normal development and neoplasia. All RUNX family members share the central Runt domain, which is well conserved and recognizes a specific DNA sequence, but each has relatively divergent N- and C-terminal regions (1). RUNX3 is involved in neurogenesis (2, 3) and thymopoiesis (4, 5) and functions as a tumor suppressor gene in gastric cancer (6, 7). Failure to express RUNX3 because of a combination of hemizygous deletion and DNA hypermethylation of the RUNX3 promoter region has been found in about 60% of primary gastric cancer specimens (7). RUNX3-R122C is a mutation located in the conserved Runt domain that was discovered in a case of gastric cancer and it abolishes the tumor suppressive activity of RUNX3 (7). Subsequent studies have revealed that RUNX3 inactivation is not limited to gastric cancer, and frequent inactivation of RUNX3 due to DNA hypermethylation has been reported in various other cancers, including lung cancer (8), hepatocellular carcinoma (9), breast cancer (10), colon cancer (11), pancreatic cancer (12), bile duct cancer (12), prostate cancer (13), and laryngeal cancer (10). Thus, RUNX3 is primarily inactivated by epigenetic silencing, rather than by mutations or deletions, suggesting that RUNX3 can be reactivated and serve as a good gene for drug targeting.
###end p 8
###begin p 9
###xml 36 37 36 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn3">2</xref>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 287 288 287 288 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 558 559 558 559 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 673 674 673 674 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 849 851 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 910 914 910 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EZH2</italic>
###xml 1136 1143 1136 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyclinA</italic>
###xml 1249 1251 1249 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 631 636 <span type="species:ncbi:10090">mouse</span>
Enhancer of zeste homologue 2 (EZH2)2 is one of the polycomb group proteins involved in the regulation of proliferation and cell cycle progression (14). More specifically, EZH2 is a histone methyltransferase controlled by the E2F transcription factors that regulate the transition from G2 to the mitotic phase of the cell cycle through nucleosome modification, chromatin remodeling, and interaction with other transcription factors (15). Disruption of EZH2 expression in senescent fibroblasts retards cell proliferation and induces cell cycle arrest at the G2 to mitosis transition (16), whereas overexpression of EZH2 in cultured mouse embryonic fibroblasts shortens the G1 phase of the cell cycle and leads to accumulation of cells in the S phase (17). EZH2 expression has been found to be linked to the progression of prostate and breast cancer (18, 19), and because it is a biomarker of tumor progression, EZH2 has also been suggested to be an oncogene that leads to tumor development. EZH2 competes with histone deacetylase in binding to retinoblastoma protein 2/p130 and subsequently reduces the transcriptional repression of the CyclinA promoter, suggesting a molecular mechanism linking elevated EZH2 expression to malignant transformation (20). However, the downstream signaling and molecular mechanism for the aberrant expression of EZH2 in cancer has been poorly understood.
###end p 9
###begin p 10
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p21</italic>
###xml 39 48 39 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WAF1/Cip1</sup>
###xml 253 255 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 258 263 255 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 321 324 318 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bim</italic>
###xml 379 381 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 390 395 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 516 521 510 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 782 787 776 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
RUNX3 has been found to up-regulate p21WAF1/Cip1, an important factor in cyclin-dependent kinase inhibition and cell cycle control, and has been found to do so in collaboration with Smads downstream of transforming growth factor-beta in gastric cancer (21). RUNX3 is also responsible for transcriptional up-regulation of Bim in transforming growth factor-beta-induced apoptosis (22). Thus, RUNX3 plays a critical role in the induction of apoptosis as well as in the regulation of cell growth arrest, suggesting that RUNX3 is a significant tumor suppressor gene in carcinogenesis. In the present study, we investigated the mechanism of the role that EZH2 plays in cancer cell proliferation in several different cancer cell lines and found that EZH2 is a transcriptional repressor of RUNX3 expression and acts synergistically with DNA methylation.
###end p 10
###begin title 11
EXPERIMENTAL PROCEDURES
###end title 11
###begin p 12
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cell Culture</italic>
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e.</italic>
###xml 382 383 376 377 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 342 348 <span type="species:ncbi:9913">bovine</span>
Cell Culture-Five human cancer cell lines, i.e. gastric cancer cell line MKN28, breast cancer cell line MCF-7, prostate cancer cell line LNCap, colon cancer cell line DLD1, and pancreatic cancer cell line MiaPaca2, were maintained at 37 degreesC in RPMI 1640 or Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum and 1% glutamine in a 5% CO2 atmosphere.
###end p 12
###begin p 13
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tissue Specimens</italic>
###xml 627 635 <span type="species:ncbi:9606">patients</span>
###xml 707 715 <span type="species:ncbi:9606">patients</span>
###xml 887 895 <span type="species:ncbi:9606">patients</span>
Tissue Specimens-A total of 17 gastric cancer specimens (stage IA, 3; IB, 4; II, 2; IIIA, 3; IIIB, 2; and IV, 3; 8 intestinal-type adenocarcinomas and 9 diffuse-type adenocarcinomas) and corresponding non-neoplastic gastric mucosa were studied. The specimens were obtained from 8 males and 9 females (mean age 62.8 years; range 52-77 years) by surgical resection at the National Cancer Hospital East and were immediately frozen in liquid nitrogen and stored at -80 degreesC until examined. The histological diagnosis was confirmed by microscopic analysis of a section of each frozen specimen before DNA extraction. None of the patients had any preoperative treatment, such as radiation or chemotherapy. All patients agreed to enrollment in the study and gave their informed consent. The institutional review board of the National Cancer Center approved all protocols after obtaining the patients' consent. All clinicopathological data were according to the TNM classification (UICC) and obtained from the clinical and pathology records.
###end p 13
###begin p 14
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNA Interference</italic>
RNA Interference-Two different 21-nucleotides duplex siRNAs for EZH2 and one negative control siRNA were synthesized by Ambion (EZH2; siRNA ID 107417 and 214022). Twenty-four hours after plating, the cells were transfected with EZH2 siRNA or control siRNA using the DharmaFECT transfection reagent (DHARMACON) according to the manufacturer's instructions. At various time points after transfection, cells were harvested and subjected to several assays, including real-time PCR and Western blotting analysis.
###end p 14
###begin p 15
###xml 0 34 0 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNA Isolation and Real-time RT-PCR</italic>
###xml 252 256 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EZH2</italic>
###xml 261 266 261 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 310 315 310 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH</italic>
###xml 555 560 555 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH</italic>
###xml 647 651 647 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EZH2</italic>
###xml 707 712 707 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 768 773 768 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH</italic>
RNA Isolation and Real-time RT-PCR-Total RNA from the five different cell lines was isolated with TRIzol Reagent (Invitrogen) and reverse transcribed to cDNA with ExScript RT Reagent (Takara). Real-time RT-PCR was carried out with specific primers for EZH2 and RUNX3 and Smart Cycler (Cepheid, Sunnyvale, CA). GAPDH expression was used to normalize for variance. Real-time fluorescence monitoring of the PCR products was performed with SYBR Green I fluorescent dye (Takara). The expression levels of specific genes are reported as ratios of expression of GAPDH in the same master reaction. The PCR primer pairs (5' to 3') used for each gene were: EZH2, CCCTGACCTCTGTCTTACTTGTGGA and ACGTCAGATGGTGCCAGCAATA; RUNX3, TCTGTAAGGCCCAAAGTGGGTA and ACCTCAGCATGACAATATGTCACAA; GAPDH, GCACCGTCAAGGCTGAGAAC and ATGGTGGTGAAGACGCCAGT.
###end p 15
###begin p 16
###xml 0 42 0 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chromatin Immunoprecipitation (ChIP) Assay</italic>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 419 424 419 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 569 570 568 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9</sup>
###xml 649 651 648 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink">27</sup>
###xml 1221 1227 1220 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
###xml 1452 1456 1451 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYT1</italic>
###xml 1558 1562 1557 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYT1</italic>
###xml 1612 1614 1611 1613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
Chromatin Immunoprecipitation (ChIP) Assay-The ChIP assay was performed as previously described (23). The PCR conditions for the RUNX3 gene promoter were applied with the following two primer pairs (5' to 3'): ChIP primer 1, TGTCCCGGGATCCTCTTCT and TAGAGACGTTGGTGCGGAAAT and ChIP primer 2, CTCTCTGCTCTCCCCTCAAAAC and GGACCGTGGTTACATGCGTAA. These primer sets were designed to encompass the transcriptional start site of RUNX3 variant 2 in the CpG island. A 5 mug amount of each antibody was used in this assay. The antibodies used were EZH2 antibody and dimethyl H3 (Lys9) antibody, purchased from Abcam Inc., and HDAC1 antibody and trimethyl H3 (Lys27) antibody, purchased from Upstate. Individual ChIP assays were repeated at least twice to confirm the reproducibility of the PCR-based experiment. Preliminary PCR were performed to determine the optimal PCR conditions to assure linear amplification of DNA. PCR products were electrophoresed on a 6% polyacrylamide gel, stained with ethidium bromide, and photographed. To measure the levels of EZH2, HDAC1, and histone methylation (K9 and K27) in each immunoprecipitate, the ratios were calculated by measuring the intensity of the PCR product in immunoprecipitated DNA versus input DNA (total chromatin) amplified by PCR in a linear range. The ratios were calculated by performing a DNA 1000 assay with the Agilent 2100 bioanalyzer and using DNA chips for electrophoresis (Agilent Technologies). The MYT1 (myelin transcription factor 1) gene was used as a positive control to validate each ChIP assay. The MYT1 gene has been found to be a target gene of EZH2 (24).
###end p 16
###begin p 17
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DNA Extraction</italic>
DNA Extraction-Genomic DNA from the five cancer cell lines and the 17 gastric cancer specimens and corresponding non-neoplastic gastric mucosa was extracted with a DNeasy tissue kit (Qiagen).
###end p 17
###begin p 18
###xml 0 49 0 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Analysis of the Methylation Status of Genomic DNA</italic>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 167 172 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 413 418 412 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 470 471 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
Analysis of the Methylation Status of Genomic DNA-Bisulfite treatment of the DNA for the methylation assays was performed as previously described (25). Methylation of RUNX3 was determined by a methylation-specific polymerase chain reaction (MSP). Briefly, 2 mul of bisulfite-treated DNA was used as the PCR template, and primer sets specific for methylated and unmethylated alleles were used. The MSP primers for RUNX3 used in this study have been described previously (7). The PCR products from the methylated and unmethylated reactions were electrophoresed on 6% polyacrylamide gels and visualized by ethidium bromide staining.
###end p 18
###begin p 19
###xml 0 18 0 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Immunofluorescence</italic>
###xml 260 262 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 148 154 <span type="species:ncbi:9986">Rabbit</span>
###xml 210 215 <span type="species:ncbi:10090">mouse</span>
###xml 279 285 <span type="species:ncbi:9793">donkey</span>
###xml 314 320 <span type="species:ncbi:9986">rabbit</span>
###xml 350 354 <span type="species:ncbi:9925">goat</span>
###xml 383 388 <span type="species:ncbi:10090">mouse</span>
Immunofluorescence-Cells grown on coverslips were fixed with 3% paraformaldehyde in phosphate-buffered saline and processed for immunofluorescence. Rabbit antibody against EZH2 (1:125) (Zymed Laboratories) and mouse antibody against RUNX3 (1 mug/ml) (R3-6E9) (26) were used. The donkey secondary antibody was anti-rabbit IgG-Alexa Fluor 488, and the goat secondary antibody was anti-mouse IgG-Alexa Fluor 546 (Molecular Probes). Cells were examined with a Zeiss LSM5 PASCAL microscope and nuclear contour ratios were computed.
###end p 19
###begin p 20
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 9 133 9 133 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Restoration of RUNX3 mRNA levels after knockdown of EZH2 in five cancer cell lines, MKN28, MCF-7, LNCap, DLD1, and MiaPaca2.</bold>
###xml 133 134 133 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 323 326 323 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a&#8211;e</italic>
###xml 364 370 364 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f&#8211;j. E</italic>
###xml 384 385 384 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 402 403 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 9 534 9 534 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="21"><bold>Restoration of RUNX3 mRNA levels after knockdown of EZH2 in five cancer cell lines, MKN28, MCF-7, LNCap, DLD1, and MiaPaca2.</bold><italic>A</italic>, the level of EZH2 mRNA after knockdown by siRNA transfection and the restored level of RUNX3 mRNA expression were quantified by real-time RT-PCR. EZH2 mRNA expression levels are shown in <italic>a&#8211;e</italic>, and RUNX3 mRNA expression levels in <italic>f&#8211;j. E</italic>, EZH2 siRNA; <italic>C</italic>, control siRNA. <italic>B</italic>, the restored RUNX3 mRNA levels in MKN28 cells were analyzed by RT-PCR and visualized by electrophoresis on 6% polyacrylamide gel.</p>
###xml 9 534 9 534 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="21"><bold>Restoration of RUNX3 mRNA levels after knockdown of EZH2 in five cancer cell lines, MKN28, MCF-7, LNCap, DLD1, and MiaPaca2.</bold><italic>A</italic>, the level of EZH2 mRNA after knockdown by siRNA transfection and the restored level of RUNX3 mRNA expression were quantified by real-time RT-PCR. EZH2 mRNA expression levels are shown in <italic>a&#8211;e</italic>, and RUNX3 mRNA expression levels in <italic>f&#8211;j. E</italic>, EZH2 siRNA; <italic>C</italic>, control siRNA. <italic>B</italic>, the restored RUNX3 mRNA levels in MKN28 cells were analyzed by RT-PCR and visualized by electrophoresis on 6% polyacrylamide gel.</p></caption>
###xml 534 534 534 534 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0280841070001"/>
###xml 0 534 0 534 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="21"><bold>Restoration of RUNX3 mRNA levels after knockdown of EZH2 in five cancer cell lines, MKN28, MCF-7, LNCap, DLD1, and MiaPaca2.</bold><italic>A</italic>, the level of EZH2 mRNA after knockdown by siRNA transfection and the restored level of RUNX3 mRNA expression were quantified by real-time RT-PCR. EZH2 mRNA expression levels are shown in <italic>a&#8211;e</italic>, and RUNX3 mRNA expression levels in <italic>f&#8211;j. E</italic>, EZH2 siRNA; <italic>C</italic>, control siRNA. <italic>B</italic>, the restored RUNX3 mRNA levels in MKN28 cells were analyzed by RT-PCR and visualized by electrophoresis on 6% polyacrylamide gel.</p></caption><graphic xlink:href="zbc0280841070001"/></fig>
FIGURE 1.Restoration of RUNX3 mRNA levels after knockdown of EZH2 in five cancer cell lines, MKN28, MCF-7, LNCap, DLD1, and MiaPaca2.A, the level of EZH2 mRNA after knockdown by siRNA transfection and the restored level of RUNX3 mRNA expression were quantified by real-time RT-PCR. EZH2 mRNA expression levels are shown in a-e, and RUNX3 mRNA expression levels in f-j. E, EZH2 siRNA; C, control siRNA. B, the restored RUNX3 mRNA levels in MKN28 cells were analyzed by RT-PCR and visualized by electrophoresis on 6% polyacrylamide gel.
###end p 20
###begin p 21
###xml 0 124 0 124 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Restoration of RUNX3 mRNA levels after knockdown of EZH2 in five cancer cell lines, MKN28, MCF-7, LNCap, DLD1, and MiaPaca2.</bold>
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 314 317 314 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a&#8211;e</italic>
###xml 355 361 355 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f&#8211;j. E</italic>
###xml 375 376 375 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 393 394 393 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
Restoration of RUNX3 mRNA levels after knockdown of EZH2 in five cancer cell lines, MKN28, MCF-7, LNCap, DLD1, and MiaPaca2.A, the level of EZH2 mRNA after knockdown by siRNA transfection and the restored level of RUNX3 mRNA expression were quantified by real-time RT-PCR. EZH2 mRNA expression levels are shown in a-e, and RUNX3 mRNA expression levels in f-j. E, EZH2 siRNA; C, control siRNA. B, the restored RUNX3 mRNA levels in MKN28 cells were analyzed by RT-PCR and visualized by electrophoresis on 6% polyacrylamide gel.
###end p 21
###begin p 22
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Western Blot Analysis</italic>
###xml 73 74 73 74 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 87 88 87 88 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 100 101 100 101 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 106 107 106 107 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 114 115 114 115 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 157 158 157 158 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 179 180 179 180 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 200 201 200 201 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 426 427 420 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 729 731 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
Western Blot Analysis-Cells were lysed with whole cell lysis buffer (50 mm HEPES, 150 mm NaCl, 1.5 mm MgCl2, 0.5 mm EDTA, 10% glycerol, 1% Triton X-100, 10 mm sodium fluoride, 1 mm dithiothreitol, 1 mm phenylmethylsulfonyl fluoride), and then frozen at -80 degreesC and thawed three times to rupture the cell membranes. Samples of the lysates were incubated for 30 min on ice to lyse the nuclei and then centrifuged at 8900 x g. The protein concentration of each sample was determined by a standard Bradford assay. Equal amounts of protein (20 mug) from each cell line were subjected to Western blot analysis. The probing antibodies were EZH2 antibody (1:1000) (BD Transduction Laboratories), RUNX3 antibody (1 mug/ml) (R3-5G4) (26), Histone H3 antibody (0.5 mug/ml) (Upstate), and beta-actin antibody (1:50) (Santa Cruz Biotechnology).
###end p 22
###begin p 23
###xml 0 53 0 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cell Treatment with Trichostatin A (TSA) and 5-Aza-dC</italic>
###xml 217 218 217 218 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 226 227 225 226 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 274 275 273 274 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 283 284 281 282 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 358 359 356 357 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 404 405 401 402 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 440 441 436 437 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 506 507 502 503 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 532 533 527 528 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Cell Treatment with Trichostatin A (TSA) and 5-Aza-dC- Preliminary experiments were performed to determine the maximum concentration tolerated of TSA and 5-aza-dC by each cell line, and TSA concentrations in the 330 nm to 5 mum range and 5-aza-dC concentrations in the 800 nm to 1 mum range were optimal for the cancer cell lines. TSA concentrations of 330 nm were used for MCF-7 and MiaPaca2 cells, 1 mum for LNCap and DLD1 cells, and 5 mum for MKN28 cells, and the 5-aza-dC concentrations used were 800 nm for MCF-7 cells and 1 mum for MKN28, LNCap, DLD1, and MiaPaca2 cells. Cells were seeded at low density in a 35-mm tissue culture dish and incubated at 37 degreesC for a total of 72 h. Cells were incubated for 24 h prior to treatment with the chemicals. Mock treatment with an identical volume of absolute ethanol or water was used as a control. The 5-aza-dC was added after 24 h of incubation and cells were incubated for 48 h after it was added. TSA was added to the medium after 24 h of incubation, and cells were incubated with TSA for 48 h. When 5-aza-dC and TSA were both added, they were added after incubation for 24 h, and cells were incubated for 48 h. The culture medium was exchanged every 24 h for 5-aza-dC, TSA, and the combined treatment. Total cellular RNA was extracted for real-time PCR analysis.
###end p 23
###begin p 24
###xml 0 24 0 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cell Proliferation Assay</italic>
###xml 230 231 230 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
Cell Proliferation Assay-The five cancer cell lines were transfected with EZH2 siRNA or control siRNA 48 h before the cell proliferation assay. The cell proliferation assay was started by seeding the cells at a density of 1.0 x 105 per dish. The assay was subsequently processed by incubating the cells at 37 degreesC in a tissue culture incubator for 72, 96, 120, and 144 h after transfection, and counting the cells to plot a cell growth curve.
###end p 24
###begin p 25
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Immunohistochemistry</italic>
###xml 234 236 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
Immunohistochemistry-The same 17 gastric adenocarcinoma specimens as used for MSP analysis were used for immunohistochemical analysis. Immunohistochemistry for EZH2 (1:25) (BD Transduction Laboratories) and RUNX3 (1 mug/ml) (R3-6E9) (26) was performed on formalin-fixed, paraffin-embedded tissue sections by steam heat-induced or microwave-induced epitope retrieval and with the Dako Envision detection system. Specimens were scored negative for overexpression of EZH2 when 0-20% of the cells were positive, and positive for overexpression when >21% cells were positive. Specimens were scored positive for RUNX3 expression and negative. For RUNX3 expression, specimens were also evaluated with the localization of RUNX3 expression, nucleus or cytoplasm. Appropriate positive and negative internal controls were used to validate immunohistochemical staining.
###end p 25
###begin title 26
RESULTS
###end title 26
###begin p 27
###xml 0 50 0 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Inhibitory Effect of EZH2 on RUNX3 Gene Expression</italic>
###xml 104 109 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 157 161 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e.</italic>
###xml 385 390 385 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 404 405 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 768 769 768 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 762 769 762 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 769 774 769 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">, a&#8211;e</italic>
###xml 1099 1100 1099 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1093 1100 1093 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 1100 1105 1100 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">, f&#8211;j</italic>
###xml 1297 1298 1297 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1291 1298 1291 1298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 1298 1303 1298 1303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">, f&#8211;j</italic>
###xml 1610 1611 1610 1611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1604 1611 1604 1611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
Inhibitory Effect of EZH2 on RUNX3 Gene Expression-To determine whether EZH2 is a negative modulator of RUNX3 gene expression in the five cancer cell lines, i.e. gastric cancer line MKN28, breast cancer line MCF-7, prostate cancer line LNCap, colon cancer line DLD1, and pancreatic cancer line MiaPaca2, EZH2 mRNA was suppressed with EZH2 siRNA in all five cancer cell lines, in which RUNX3 is silenced (7, 11, 12, 27, 28). The results of RT-PCR showed significantly decreased levels of EZH2 mRNA in all five cancer cell lines within 48-96 h after transfection with EZH2 siRNA (the percentage of EZH2 mRNA expression level by EZH2 siRNA transfection to that by control siRNA transfection; MKN28, 31.6%; MCF-7, 25.7%; LNCap, 31.5%; DLD1, 50.0%; MiaPaca2, 47.0%) (Fig. 1A, a-e). A marked decrease in EZH2 protein level in all five cancer cell lines was observed by Western blot 96 h after transfection (data not shown), an increased level of RUNX3 mRNA was in every line. Real-time RT-PCR was performed to quantitatively measure the restored RUNX3 mRNA expression level after knockdown of EZH2 (Fig. 1A, f-j). RUNX3 mRNA had increased from 3.5 to 10.4-fold after EZH2 knockdown in the cancer cell lines (MKN28, 4.7-fold; MCF-7, 6.1-fold; LNCap, 10.4-fold; DLD1, 4.1-fold; MiaPaca2, 3.5-fold) (Fig. 1A, f-j). However, the transcriptional expression level of GAPDH mRNA was unchanged in all five cancer cell lines after EZH2 knockdown, suggesting that GAPDH is not a target of EZH2 (data not shown). By non-real-time RT-PCR, restoration of RUNX3 mRNA expression in the MKN28 cells was visualized on 6% PAGE (Fig. 1B).
###end p 27
###begin p 28
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 217 222 217 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 9 228 9 228 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Restoration of RUNX3 mRNA in gastric and breast cancer cell lines (MKN28 and MCF-7) after EZH2 knockdown accompanied by chromatin remodeling with no change of DNA methylation status in the promoter region of <italic>RUNX3</italic> gene.</bold>
###xml 228 232 228 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A, a</italic>
###xml 237 238 237 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 469 471 469 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink">27</sup>
###xml 533 534 533 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9</sup>
###xml 621 622 621 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 647 648 647 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 787 792 787 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">under</italic>
###xml 866 868 866 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 879 881 879 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 895 897 895 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 906 907 906 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 913 917 913 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYT1</italic>
###xml 1018 1019 1018 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1196 1197 1196 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 1220 1221 1220 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">U</italic>
###xml 1326 1328 1326 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ma</italic>
###xml 9 1367 9 1367 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="29"><bold>Restoration of RUNX3 mRNA in gastric and breast cancer cell lines (MKN28 and MCF-7) after EZH2 knockdown accompanied by chromatin remodeling with no change of DNA methylation status in the promoter region of <italic>RUNX3</italic> gene.</bold><italic>A, a</italic> and <italic>b</italic>, ChIP assay was performed by using the DNA-protein complex isolated from MKN28 and MCF-7 cells transfected with EZH2 siRNA for 96 h and immunoprecipitated with various antibodies, including EZH2 antibody, H3K27me3 antibody (H3-Lys<sup>27</sup> trimethylation), HDAC1 antibody, and H3K9me2 antibody (H3-Lys<sup>9</sup> dimethylation). The two primer sets for ChIP assay were designated ChIP primer set 1 (<italic>a</italic>) and ChIP primer set 2 (<italic>b</italic>). The PCR products of each immunoprecipitated DNA and input DNA were visualized by electrophoresis on a 6% polyacrylamide gel. The number <italic>under</italic> each gel is the ratio of immunoprecipitated DNA to input DNA quantified (<italic>A,</italic> antibody; <italic>B,</italic> no antibody; <italic>C,</italic> input). <italic>c</italic>, the <italic>MYT1</italic> gene, which is known to be a target of EZH2, was used to validate ChIP assays in the present study. <italic>B</italic>, MSP analyses of the DNA of the five cancer cell lines transfected with EZH2 siRNA or negative control siRNA, using primer sets that specifically amplify either methylated DNA(<italic>M</italic>) or unmethylated DNA (<italic>U</italic>). Control templates from human genomic placenta DNA treated or untreated with SssI methylase are shown. <italic>Ma</italic>, 200-bp and 300-bp DNA ladder markers.</p>
###xml 9 1367 9 1367 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="29"><bold>Restoration of RUNX3 mRNA in gastric and breast cancer cell lines (MKN28 and MCF-7) after EZH2 knockdown accompanied by chromatin remodeling with no change of DNA methylation status in the promoter region of <italic>RUNX3</italic> gene.</bold><italic>A, a</italic> and <italic>b</italic>, ChIP assay was performed by using the DNA-protein complex isolated from MKN28 and MCF-7 cells transfected with EZH2 siRNA for 96 h and immunoprecipitated with various antibodies, including EZH2 antibody, H3K27me3 antibody (H3-Lys<sup>27</sup> trimethylation), HDAC1 antibody, and H3K9me2 antibody (H3-Lys<sup>9</sup> dimethylation). The two primer sets for ChIP assay were designated ChIP primer set 1 (<italic>a</italic>) and ChIP primer set 2 (<italic>b</italic>). The PCR products of each immunoprecipitated DNA and input DNA were visualized by electrophoresis on a 6% polyacrylamide gel. The number <italic>under</italic> each gel is the ratio of immunoprecipitated DNA to input DNA quantified (<italic>A,</italic> antibody; <italic>B,</italic> no antibody; <italic>C,</italic> input). <italic>c</italic>, the <italic>MYT1</italic> gene, which is known to be a target of EZH2, was used to validate ChIP assays in the present study. <italic>B</italic>, MSP analyses of the DNA of the five cancer cell lines transfected with EZH2 siRNA or negative control siRNA, using primer sets that specifically amplify either methylated DNA(<italic>M</italic>) or unmethylated DNA (<italic>U</italic>). Control templates from human genomic placenta DNA treated or untreated with SssI methylase are shown. <italic>Ma</italic>, 200-bp and 300-bp DNA ladder markers.</p></caption>
###xml 1367 1367 1367 1367 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0280841070002"/>
###xml 0 1367 0 1367 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="29"><bold>Restoration of RUNX3 mRNA in gastric and breast cancer cell lines (MKN28 and MCF-7) after EZH2 knockdown accompanied by chromatin remodeling with no change of DNA methylation status in the promoter region of <italic>RUNX3</italic> gene.</bold><italic>A, a</italic> and <italic>b</italic>, ChIP assay was performed by using the DNA-protein complex isolated from MKN28 and MCF-7 cells transfected with EZH2 siRNA for 96 h and immunoprecipitated with various antibodies, including EZH2 antibody, H3K27me3 antibody (H3-Lys<sup>27</sup> trimethylation), HDAC1 antibody, and H3K9me2 antibody (H3-Lys<sup>9</sup> dimethylation). The two primer sets for ChIP assay were designated ChIP primer set 1 (<italic>a</italic>) and ChIP primer set 2 (<italic>b</italic>). The PCR products of each immunoprecipitated DNA and input DNA were visualized by electrophoresis on a 6% polyacrylamide gel. The number <italic>under</italic> each gel is the ratio of immunoprecipitated DNA to input DNA quantified (<italic>A,</italic> antibody; <italic>B,</italic> no antibody; <italic>C,</italic> input). <italic>c</italic>, the <italic>MYT1</italic> gene, which is known to be a target of EZH2, was used to validate ChIP assays in the present study. <italic>B</italic>, MSP analyses of the DNA of the five cancer cell lines transfected with EZH2 siRNA or negative control siRNA, using primer sets that specifically amplify either methylated DNA(<italic>M</italic>) or unmethylated DNA (<italic>U</italic>). Control templates from human genomic placenta DNA treated or untreated with SssI methylase are shown. <italic>Ma</italic>, 200-bp and 300-bp DNA ladder markers.</p></caption><graphic xlink:href="zbc0280841070002"/></fig>
###xml 1247 1252 <span type="species:ncbi:9606">human</span>
FIGURE 2.Restoration of RUNX3 mRNA in gastric and breast cancer cell lines (MKN28 and MCF-7) after EZH2 knockdown accompanied by chromatin remodeling with no change of DNA methylation status in the promoter region of RUNX3 gene.A, a and b, ChIP assay was performed by using the DNA-protein complex isolated from MKN28 and MCF-7 cells transfected with EZH2 siRNA for 96 h and immunoprecipitated with various antibodies, including EZH2 antibody, H3K27me3 antibody (H3-Lys27 trimethylation), HDAC1 antibody, and H3K9me2 antibody (H3-Lys9 dimethylation). The two primer sets for ChIP assay were designated ChIP primer set 1 (a) and ChIP primer set 2 (b). The PCR products of each immunoprecipitated DNA and input DNA were visualized by electrophoresis on a 6% polyacrylamide gel. The number under each gel is the ratio of immunoprecipitated DNA to input DNA quantified (A, antibody; B, no antibody; C, input). c, the MYT1 gene, which is known to be a target of EZH2, was used to validate ChIP assays in the present study. B, MSP analyses of the DNA of the five cancer cell lines transfected with EZH2 siRNA or negative control siRNA, using primer sets that specifically amplify either methylated DNA(M) or unmethylated DNA (U). Control templates from human genomic placenta DNA treated or untreated with SssI methylase are shown. Ma, 200-bp and 300-bp DNA ladder markers.
###end p 28
###begin p 29
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 0 219 0 219 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Restoration of RUNX3 mRNA in gastric and breast cancer cell lines (MKN28 and MCF-7) after EZH2 knockdown accompanied by chromatin remodeling with no change of DNA methylation status in the promoter region of <italic>RUNX3</italic> gene.</bold>
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A, a</italic>
###xml 228 229 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 460 462 460 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink">27</sup>
###xml 524 525 524 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9</sup>
###xml 612 613 612 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 638 639 638 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 778 783 778 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">under</italic>
###xml 857 859 857 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 870 872 870 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 886 888 886 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 897 898 897 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 904 908 904 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYT1</italic>
###xml 1009 1010 1009 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1187 1188 1187 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 1211 1212 1211 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">U</italic>
###xml 1317 1319 1317 1319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ma</italic>
###xml 1238 1243 <span type="species:ncbi:9606">human</span>
Restoration of RUNX3 mRNA in gastric and breast cancer cell lines (MKN28 and MCF-7) after EZH2 knockdown accompanied by chromatin remodeling with no change of DNA methylation status in the promoter region of RUNX3 gene.A, a and b, ChIP assay was performed by using the DNA-protein complex isolated from MKN28 and MCF-7 cells transfected with EZH2 siRNA for 96 h and immunoprecipitated with various antibodies, including EZH2 antibody, H3K27me3 antibody (H3-Lys27 trimethylation), HDAC1 antibody, and H3K9me2 antibody (H3-Lys9 dimethylation). The two primer sets for ChIP assay were designated ChIP primer set 1 (a) and ChIP primer set 2 (b). The PCR products of each immunoprecipitated DNA and input DNA were visualized by electrophoresis on a 6% polyacrylamide gel. The number under each gel is the ratio of immunoprecipitated DNA to input DNA quantified (A, antibody; B, no antibody; C, input). c, the MYT1 gene, which is known to be a target of EZH2, was used to validate ChIP assays in the present study. B, MSP analyses of the DNA of the five cancer cell lines transfected with EZH2 siRNA or negative control siRNA, using primer sets that specifically amplify either methylated DNA(M) or unmethylated DNA (U). Control templates from human genomic placenta DNA treated or untreated with SssI methylase are shown. Ma, 200-bp and 300-bp DNA ladder markers.
###end p 29
###begin p 30
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ChIP Assay</italic>
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 375 379 375 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYT1</italic>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 494 499 494 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 560 561 560 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 554 561 554 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 561 564 561 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">, a</italic>
###xml 569 570 569 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 636 641 636 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 744 746 744 746 <sup xmlns:xlink="http://www.w3.org/1999/xlink">27</sup>
###xml 769 774 769 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 890 892 890 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink">27</sup>
###xml 972 977 972 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 1017 1022 1017 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 1206 1211 1206 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 1321 1322 1321 1322 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9</sup>
###xml 1483 1484 1483 1484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9</sup>
###xml 1534 1539 1534 1539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 1626 1631 1626 1631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 1704 1706 1704 1706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">27</sup>
###xml 1732 1733 1732 1733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1726 1733 1726 1733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 1733 1736 1733 1736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">, c</italic>
###xml 1796 1798 1796 1798 <sup xmlns:xlink="http://www.w3.org/1999/xlink">27</sup>
###xml 1822 1826 1822 1826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYT1</italic>
###xml 1883 1885 1883 1885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
ChIP Assay-To demonstrate a direct interaction between the EZH2 complex and promoter region of the RUNX3 gene, a ChIP assay was performed using the same MKN28 and MCF-7 cells. Two PCR primer sets that spanned the transcriptional start site were used to monitor binding of EZH2 to the promoter that drives expression of RUNX3 mRNA and was up-regulated after loss of EZH2. The MYT1 gene was used as a positive control to validate each ChIP assay (25). The ChIP assay revealed EZH2 binding to the RUNX3 promoter region in the control MKN28 and MCF-7 cells (Fig. 2A, a and b), and the amount of the EZH2 recruited to the promoter region of RUNX3 was inversely correlated with the RUNX3 mRNA expression levels in both cell lines. The level of H3-Lys27 trimethylation in the RUNX3 promoter was significantly reduced in MKN28 and MCF-7 cells transfected with EZH2 siRNA, and the decrease in H3-Lys27 trimethylation was inversely correlated with the increase in expression of the RUNX3 gene. The amount of HDAC1 bound to the RUNX3 promoter was also significantly reduced in MKN28 and MCF-7 cells transfected with EZH2 siRNA, and the decrease in HDAC1 was inversely correlated with an increase in expression of the RUNX3 gene, suggesting that EZH2 forms a transcriptional repressive complex with HDAC1. A decreased level of H3-Lys9 dimethylation was also detected in MKN28 cells transfected with EZH2 siRNA in comparison with MKN28 cells transfected with control siRNA, suggesting that H3-Lys9 status may also be involved in modulation of the RUNX3 gene promoter activity by EZH2. Based on all of the above findings, we concluded that RUNX3 gene silencing in cancer cells is mediated by EZH2 increasing the H3-Lys27 methylation level. Fig. 2A, c, shows that the binding levels of EZH2 and H3K27me3 (H3-Lys27 trimethylation) in the MYT1 promoter region, which is known to be a target of EZH2 (25), clearly decreased after knockdown of EZH2, suggesting the ChIP assay was valid. The means and standard deviations of ChIP experiments for each antibody were shown as diagrams (supplemental Fig. S1).
###end p 30
###begin p 31
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 9 140 9 140 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Restoration of <italic>RUNX3</italic> expression in five cancer cell lines after treatment with 5-aza-dC, TSA, or a combination of 5-aza-dC and TSA.</bold>
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 223 224 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 233 234 233 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 243 244 243 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 253 254 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 266 267 266 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 383 389 383 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 396 403 396 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vehicle</italic>
###xml 427 430 427 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AZA</italic>
###xml 442 443 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 444 445 444 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 9 479 9 479 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32"><bold>Restoration of <italic>RUNX3</italic> expression in five cancer cell lines after treatment with 5-aza-dC, TSA, or a combination of 5-aza-dC and TSA.</bold><italic>RUNX3</italic> expression in the five lines was evaluated by quantitative real-time RT-PCR. <italic>A</italic>, MKN28; <italic>B</italic>, MCF-7; <italic>C</italic>, LNCap; <italic>D</italic>, DLD1, and <italic>E</italic>, MiaPaca2. The concentrations of 5-aza-dC and TSA to which the MCF-7 line was exposed were the same as used by Lau <italic>et al.</italic> (<xref ref-type="bibr" rid="ref26">26</xref>). <italic>Vehicle</italic>, no treatment control; <italic>AZA</italic>, 5-aza-dC; <italic>A</italic>+<italic>T</italic>, combination of 5-aza-dC and TSA.</p>
###xml 9 479 9 479 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="32"><bold>Restoration of <italic>RUNX3</italic> expression in five cancer cell lines after treatment with 5-aza-dC, TSA, or a combination of 5-aza-dC and TSA.</bold><italic>RUNX3</italic> expression in the five lines was evaluated by quantitative real-time RT-PCR. <italic>A</italic>, MKN28; <italic>B</italic>, MCF-7; <italic>C</italic>, LNCap; <italic>D</italic>, DLD1, and <italic>E</italic>, MiaPaca2. The concentrations of 5-aza-dC and TSA to which the MCF-7 line was exposed were the same as used by Lau <italic>et al.</italic> (<xref ref-type="bibr" rid="ref26">26</xref>). <italic>Vehicle</italic>, no treatment control; <italic>AZA</italic>, 5-aza-dC; <italic>A</italic>+<italic>T</italic>, combination of 5-aza-dC and TSA.</p></caption>
###xml 479 479 479 479 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0280841070003"/>
###xml 0 479 0 479 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="32"><bold>Restoration of <italic>RUNX3</italic> expression in five cancer cell lines after treatment with 5-aza-dC, TSA, or a combination of 5-aza-dC and TSA.</bold><italic>RUNX3</italic> expression in the five lines was evaluated by quantitative real-time RT-PCR. <italic>A</italic>, MKN28; <italic>B</italic>, MCF-7; <italic>C</italic>, LNCap; <italic>D</italic>, DLD1, and <italic>E</italic>, MiaPaca2. The concentrations of 5-aza-dC and TSA to which the MCF-7 line was exposed were the same as used by Lau <italic>et al.</italic> (<xref ref-type="bibr" rid="ref26">26</xref>). <italic>Vehicle</italic>, no treatment control; <italic>AZA</italic>, 5-aza-dC; <italic>A</italic>+<italic>T</italic>, combination of 5-aza-dC and TSA.</p></caption><graphic xlink:href="zbc0280841070003"/></fig>
FIGURE 3.Restoration of RUNX3 expression in five cancer cell lines after treatment with 5-aza-dC, TSA, or a combination of 5-aza-dC and TSA.RUNX3 expression in the five lines was evaluated by quantitative real-time RT-PCR. A, MKN28; B, MCF-7; C, LNCap; D, DLD1, and E, MiaPaca2. The concentrations of 5-aza-dC and TSA to which the MCF-7 line was exposed were the same as used by Lau et al. (26). Vehicle, no treatment control; AZA, 5-aza-dC; A+T, combination of 5-aza-dC and TSA.
###end p 31
###begin p 32
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 0 131 0 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Restoration of <italic>RUNX3</italic> expression in five cancer cell lines after treatment with 5-aza-dC, TSA, or a combination of 5-aza-dC and TSA.</bold>
###xml 131 136 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 214 215 214 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 224 225 224 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 234 235 234 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 244 245 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 257 258 257 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 374 380 374 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 387 394 387 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vehicle</italic>
###xml 418 421 418 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AZA</italic>
###xml 433 434 433 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 435 436 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
Restoration of RUNX3 expression in five cancer cell lines after treatment with 5-aza-dC, TSA, or a combination of 5-aza-dC and TSA.RUNX3 expression in the five lines was evaluated by quantitative real-time RT-PCR. A, MKN28; B, MCF-7; C, LNCap; D, DLD1, and E, MiaPaca2. The concentrations of 5-aza-dC and TSA to which the MCF-7 line was exposed were the same as used by Lau et al. (26). Vehicle, no treatment control; AZA, 5-aza-dC; A+T, combination of 5-aza-dC and TSA.
###end p 32
###begin p 33
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MSP Analysis</italic>
###xml 61 66 61 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 168 169 168 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 162 169 162 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
###xml 254 259 254 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 371 376 371 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 443 444 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 437 444 437 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 507 512 507 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 570 575 570 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 763 768 763 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 896 901 896 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
MSP Analysis-As previously reported, hypermethylation in the RUNX3 promoter region was observed in all five cancer cell lines in the absence of RUNX3 expression (Fig. 2B) (7, 11, 12, 27). We then investigated whether the status of DNA methylation in the RUNX3 promoter region changed after knockdown of EZH2 and resulted in restoration of RUNX3 gene expression. Although RUNX3 was up-regulated after EZH2 siRNA transfection, as shown in Fig. 2B the MSP analysis showed no decrease in DNA methylation of the RUNX3 promoter region. Hypermethylation of the promoter of the RUNX3 gene occurred before and after EZH2 siRNA transfection in all five cancer cell lines examined. DNA hypermethylation in the promoter region is known to be associated with silencing of the RUNX3 gene, however, the above findings suggest that histone modification by EZH2 also played an important role in the regulation of RUNX3 in all five cancer cell lines.
###end p 33
###begin p 34
###xml 0 36 0 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cell Treatment with TSA and 5-Aza-dC</italic>
###xml 124 129 124 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 384 389 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 503 506 503 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;E</italic>
###xml 495 506 495 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, <italic>A&#8211;E</italic></xref>
###xml 594 595 594 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 588 595 588 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 686 691 686 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 712 715 712 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;E</italic>
###xml 704 715 704 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, <italic>A&#8211;E</italic></xref>
###xml 804 809 804 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 846 849 846 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;E</italic>
###xml 838 849 838 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, <italic>A&#8211;E</italic></xref>
###xml 907 912 907 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 1102 1107 1102 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 1376 1381 1376 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 1407 1412 1407 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 1523 1528 1523 1528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
Cell Treatment with TSA and 5-Aza-dC-To determine the relative contribution of DNA methylation and histone deacetylation to RUNX3 silencing, we investigated the effect of a demethylating agent, 5-aza-2'-deoxycytidine (5-aza-dC), and a histone deacetylase inhibitor, TSA, in all five cancer cell lines. Real-time RT-PCR showed that exposure to 5-aza-dC resulted in less restoration of RUNX3 expression than exposure to TSA in four of the cancer cell lines, the exception being the MiaPaca2 line (Fig. 3, A-E), but MSP analysis showed hypermethylation of CpG in all five cancer cell lines (Fig. 2B). Although the histone deacetylase inhibitor TSA alone was sufficient to strongly restore RUNX3 expression (Fig. 3, A-E), the combination of DNA demethylation and inhibition of histone deacetylation restored RUNX3 expression synergistically (Fig. 3, A-E). In other words, the effect of histone deacetylation on RUNX3 transcriptional repression was greater than that of DNA methylation, except in cell line MiaPaca2. Thus, both histone deacetylation and DNA methylation play a synergistic role in silencing RUNX3 expression. Neither 5-aza-dC nor TSA changed the EZH2 expression levels in any of the cancer cell lines (data not shown). As stated above, the ChIP assay showed that down-regulation of EZH2 by siRNA transfection reversed the binding of HDAC1 to the promoter region of RUNX3, which is restoration of RUNX3 expression. These findings could explain why knockdown of EZH2 by siRNA transfection was capable of restoring RUNX3 expression.
###end p 34
###begin p 35
###xml 0 74 0 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Knockdown of EZH2-induced RUNX3 Protein Expression in Gastric Cancer Cells</italic>
###xml 419 420 419 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 413 420 413 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 557 558 557 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 551 558 551 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
Knockdown of EZH2-induced RUNX3 Protein Expression in Gastric Cancer Cells-To determine whether EZH2 down-regulates the RUNX3 protein, we used immunofluorescence to investigate whether a decrease in the EZH2 protein level would restore RUNX3 protein expression. A Western blot analysis in the MKN28 cells following knockdown of EZH2 by siRNA transfection showed that RUNX3 protein was significantly up-regulated (Fig. 4A). Immunofluorescence staining confirmed that expression of the RUNX3 protein had been restored in both the nucleus and cytoplasm (Fig. 4B), and this finding demonstrated that EZH2 overexpression down-regulates RUNX3 protein in cancer cells.
###end p 35
###begin p 36
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 4.</label>
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 9 111 9 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Knockdown of EZH2-restored <italic>RUNX3</italic> expression and decreased cell proliferation by the cancer cell lines.</bold>
###xml 111 112 111 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 217 218 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 333 338 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 347 350 347 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 476 477 467 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 596 597 587 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 677 681 668 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bars</italic>
###xml 776 777 767 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 786 787 777 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 796 797 787 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 806 807 797 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 815 816 806 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 9 827 9 818 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="37"><bold>Knockdown of EZH2-restored <italic>RUNX3</italic> expression and decreased cell proliferation by the cancer cell lines.</bold><italic>A</italic>, RUNX3 re-expression in MKN28 cells was detected by Western blot analysis at 96 h after EZH2 knockdown. <italic>B</italic>, the nuclear and cytoplasmic distribution of RUNX3 was restored in MKN28 cells transfected with EZH2 siRNA (EZH2, <italic>green</italic>; RUNX3, <italic>red</italic>). DRAQ5&#8482; (1,5-bis[[2-(dimethylamino)ethyl]amino]-4,8-dihydroxyanthracene-9,10-dione]) was used to stain the nuclei. <italic>C</italic>, 48 h after transfection with EZH2 siRNA or control siRNA, cells were re-seeded in new dishes at a density of 1.0 &#215; 10<sup>5</sup> cells and counted. Points are mean of data from three independent experiments; <italic>bars</italic>, S.D. Cell proliferation by all five cell lines decreased after transfection with EZH2 siRNA. <italic>a</italic>, MKN28; <italic>b</italic>, MCF-7; <italic>c</italic>, LNCap; <italic>d</italic>, DLD1; <italic>e</italic>, MiaPaca2.</p>
###xml 9 827 9 818 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="37"><bold>Knockdown of EZH2-restored <italic>RUNX3</italic> expression and decreased cell proliferation by the cancer cell lines.</bold><italic>A</italic>, RUNX3 re-expression in MKN28 cells was detected by Western blot analysis at 96 h after EZH2 knockdown. <italic>B</italic>, the nuclear and cytoplasmic distribution of RUNX3 was restored in MKN28 cells transfected with EZH2 siRNA (EZH2, <italic>green</italic>; RUNX3, <italic>red</italic>). DRAQ5&#8482; (1,5-bis[[2-(dimethylamino)ethyl]amino]-4,8-dihydroxyanthracene-9,10-dione]) was used to stain the nuclei. <italic>C</italic>, 48 h after transfection with EZH2 siRNA or control siRNA, cells were re-seeded in new dishes at a density of 1.0 &#215; 10<sup>5</sup> cells and counted. Points are mean of data from three independent experiments; <italic>bars</italic>, S.D. Cell proliferation by all five cell lines decreased after transfection with EZH2 siRNA. <italic>a</italic>, MKN28; <italic>b</italic>, MCF-7; <italic>c</italic>, LNCap; <italic>d</italic>, DLD1; <italic>e</italic>, MiaPaca2.</p></caption>
###xml 827 827 818 818 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0280841070004"/>
###xml 0 827 0 818 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig4"><label>FIGURE 4.</label><caption><p textid="37"><bold>Knockdown of EZH2-restored <italic>RUNX3</italic> expression and decreased cell proliferation by the cancer cell lines.</bold><italic>A</italic>, RUNX3 re-expression in MKN28 cells was detected by Western blot analysis at 96 h after EZH2 knockdown. <italic>B</italic>, the nuclear and cytoplasmic distribution of RUNX3 was restored in MKN28 cells transfected with EZH2 siRNA (EZH2, <italic>green</italic>; RUNX3, <italic>red</italic>). DRAQ5&#8482; (1,5-bis[[2-(dimethylamino)ethyl]amino]-4,8-dihydroxyanthracene-9,10-dione]) was used to stain the nuclei. <italic>C</italic>, 48 h after transfection with EZH2 siRNA or control siRNA, cells were re-seeded in new dishes at a density of 1.0 &#215; 10<sup>5</sup> cells and counted. Points are mean of data from three independent experiments; <italic>bars</italic>, S.D. Cell proliferation by all five cell lines decreased after transfection with EZH2 siRNA. <italic>a</italic>, MKN28; <italic>b</italic>, MCF-7; <italic>c</italic>, LNCap; <italic>d</italic>, DLD1; <italic>e</italic>, MiaPaca2.</p></caption><graphic xlink:href="zbc0280841070004"/></fig>
FIGURE 4.Knockdown of EZH2-restored RUNX3 expression and decreased cell proliferation by the cancer cell lines.A, RUNX3 re-expression in MKN28 cells was detected by Western blot analysis at 96 h after EZH2 knockdown. B, the nuclear and cytoplasmic distribution of RUNX3 was restored in MKN28 cells transfected with EZH2 siRNA (EZH2, green; RUNX3, red). DRAQ5trade mark (1,5-bis[[2-(dimethylamino)ethyl]amino]-4,8-dihydroxyanthracene-9,10-dione]) was used to stain the nuclei. C, 48 h after transfection with EZH2 siRNA or control siRNA, cells were re-seeded in new dishes at a density of 1.0 x 105 cells and counted. Points are mean of data from three independent experiments; bars, S.D. Cell proliferation by all five cell lines decreased after transfection with EZH2 siRNA. a, MKN28; b, MCF-7; c, LNCap; d, DLD1; e, MiaPaca2.
###end p 36
###begin p 37
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 0 102 0 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Knockdown of EZH2-restored <italic>RUNX3</italic> expression and decreased cell proliferation by the cancer cell lines.</bold>
###xml 102 103 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 208 209 208 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 324 329 324 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 338 341 338 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 467 468 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 587 588 578 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 668 672 659 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bars</italic>
###xml 767 768 758 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 777 778 768 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 787 788 778 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 797 798 788 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 806 807 797 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
Knockdown of EZH2-restored RUNX3 expression and decreased cell proliferation by the cancer cell lines.A, RUNX3 re-expression in MKN28 cells was detected by Western blot analysis at 96 h after EZH2 knockdown. B, the nuclear and cytoplasmic distribution of RUNX3 was restored in MKN28 cells transfected with EZH2 siRNA (EZH2, green; RUNX3, red). DRAQ5trade mark (1,5-bis[[2-(dimethylamino)ethyl]amino]-4,8-dihydroxyanthracene-9,10-dione]) was used to stain the nuclei. C, 48 h after transfection with EZH2 siRNA or control siRNA, cells were re-seeded in new dishes at a density of 1.0 x 105 cells and counted. Points are mean of data from three independent experiments; bars, S.D. Cell proliferation by all five cell lines decreased after transfection with EZH2 siRNA. a, MKN28; b, MCF-7; c, LNCap; d, DLD1; e, MiaPaca2.
###end p 37
###begin p 38
###xml 0 57 0 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EZH2 Knockdown Had an Effect on Cancer Cell Proliferation</italic>
###xml 170 173 170 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p21</italic>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 316 321 316 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 711 712 711 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 705 712 705 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 893 894 893 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 887 894 887 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 897 898 897 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 906 907 906 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
EZH2 Knockdown Had an Effect on Cancer Cell Proliferation- At least part of the tumor suppressor activity of RUNX3 is thought to be associated with its ability to induce p21 expression (21). Loss of RUNX3 is thought to play a critical role in the process of tumor cell proliferation, and because EZH2 down-regulates RUNX3 expression, we investigated the effect of EZH2 on cell proliferation by testing the growth inhibitory effect of EZH2 siRNA in all five cancer cell lines, gastric cancer, breast cancer, prostate cancer, colon cancer, and pancreatic cancer lines. At 48 h after transfection with EZH2 siRNA or control siRNA, cells were re-seeded in new plates and observed for cell growth. As shown in Fig. 4C, cell growth started 24 h after re-seeding (72 h after transfection), and there was significantly less cell growth by the EZH2 siRNA-treated cells than by the control cells (Fig. 4C) (t test) (p < 0.05).
###end p 38
###begin p 39
###xml 0 87 0 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EZH2 Overexpression Also Correlated with Loss of RUNX3 in Gastric Adenocarcinoma Tissue</italic>
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 335 340 335 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 477 482 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 547 550 547 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;C</italic>
###xml 539 550 539 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, <italic>A&#8211;C</italic></xref>
###xml 578 583 578 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 617 624 617 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 771 776 771 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 973 980 973 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1047 1054 1047 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1156 1157 1156 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1150 1157 1150 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 2103 2104 2103 2104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 2097 2104 2097 2104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 2104 2112 2104 2112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">, center</italic>
###xml 2115 2117 2115 2117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 2211 2218 2211 2218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 2404 2409 2404 2409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 2480 2481 2480 2481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 2474 2481 2474 2481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 2625 2630 2625 2630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 2665 2666 2665 2666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 2659 2666 2659 2666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>C</italic></xref>
###xml 2728 2733 2728 2733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 2892 2894 2892 2894 <sup xmlns:xlink="http://www.w3.org/1999/xlink">27</sup>
###xml 2918 2925 2918 2925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 3174 3176 3174 3176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in</italic>
###xml 3176 3180 3176 3180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vivo</italic>
###xml 986 994 <span type="species:ncbi:9606">patients</span>
EZH2 Overexpression Also Correlated with Loss of RUNX3 in Gastric Adenocarcinoma Tissue-Because EZH2 overexpression correlated with loss of RUNX3 expression in all five cancer cell lines examined in this study and HDAC1-mediated histone modification by EZH2 acted synergistically with DNA methylation in the promoter region to silence RUNX3 expression, we investigated cancer tissue specimens for such a correlation to determine whether this repressive synergism would silence RUNX3 expression in a clinicopathologically relevant context (Fig. 5, A-C). To determine whether the RUNX3 silencing pathway by EZH2 exists in vivo, immunohistochemical staining was used to examine 17 gastric adenocarcinomas and adjacent non-cancerous gastric mucosa for DNA methylation in the RUNX3 promoter, overexpression of EZH2 protein, and RUNX3 expression. To test for DNA methylation and/or histone modification by EZH overexpression, we investigated individual cases with gastric cancer in vivo. The patients' profiles and clinicopathological data are shown in Table 1. The MSP analysis showed DNA hypermethylation in 64.7% (11/17) of the gastric adenocarcinomas (Fig. 5A). Immunohistochemical staining showed a slight difference in the distribution of RUNX3-positive cells in the fundic gland and pyloric gland portions. In the fundic gland portion, RUNX3-positive cells were observed mainly in a deeper zone of the fundic glands, corresponding to chief cells morphologically. A slight amount of RUNX3 protein was also detected in the surface epithelial cells in the gastric pits. In the pyloric gland portion, scattered RUNX3-positive cells were observed in the lower half of the antral mucosa near the generative zone. In contrast to the surrounding non-cancerous epithelial cells, weak to moderate cytoplasmic and/or nuclear positivity was observed in the gastric cancer cells in some of the specimens (5/17, 29.4%). EZH2 is normally expressed in the neck region of the gastric foveolae, which is the proliferative zone for gastric mucosa (data not shown) and in the germinal center follicular lymphocytes (Fig. 5B, center) (29). The percentage of specimens that showed overexpression of EZH2 (described as "positive" in Table 1) according to the results of immunohistochemical staining was 82.3% (14/17). Interestingly, all (case numbers 13, 15, and 17) of three specimens with DNA methylation in the promoter of RUNX3 and negativity for EZH2 overexpression showed RUNX3 expression (Fig. 5B). On the other hand, four (case numbers 2, 5, 6, and 8) of five specimens without both RUNX3 expression and DNA methylation in the promoter of RUNX3 showed EZH2 overexpression (Fig. 5C). Even in some specimens without DNA hypermethylation of the RUNX3 gene, RUNX3 protein expression was lost when EZH2 was overexpressed. This suggests that the loss of RUNX3 expression is mediated by histone methylation at Lys27 by EZH2 overexpression in vivo. Moreover, no DNA methylation or EZH2 overexpression was observed in one specimen (case number 15) showed RUNX3 expression. These results seem to mean that the effects on RUNX3 expression described above are not limited to cultured cells but occur invivo as well. However, RUNX3 expression was detected in one specimen (case number 7) despite the presence of both DNA methylation and EZH2 overexpression. This finding seems to suggest the existence of an unknown mechanism of RUNX3 repression and further study will be necessary.
###end p 39
###begin p 40
###xml 0 7 0 7 <label xmlns:xlink="http://www.w3.org/1999/xlink">TABLE 1</label>
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 7 129 7 129 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Relationship between <italic>RUNX3</italic> methylation, overexpression of EZH2 protein, and loss of RUNX3 protein in gastric cancer tissue</bold>
###xml 7 129 7 129 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="41"><bold>Relationship between <italic>RUNX3</italic> methylation, overexpression of EZH2 protein, and loss of RUNX3 protein in gastric cancer tissue</bold></p>
###xml 7 129 7 129 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="41"><bold>Relationship between <italic>RUNX3</italic> methylation, overexpression of EZH2 protein, and loss of RUNX3 protein in gastric cancer tissue</bold></p></caption>
###xml 129 137 129 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Case No.</bold>
###xml 129 137 129 137 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Case No.</bold></th>
###xml 137 140 137 140 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Age</bold>
###xml 137 140 137 140 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Age</bold></th>
###xml 140 146 140 146 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Gender</bold>
###xml 140 146 140 146 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Gender</bold></th>
###xml 146 155 146 155 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Histology</bold>
###xml 155 156 155 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 155 156 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>a</sup></italic>
###xml 155 156 155 156 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic><sup>a</sup></italic></bold>
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn1"><bold><italic><sup>a</sup></italic></bold></xref>
###xml 146 156 146 156 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Histology</bold><xref ref-type="table-fn" rid="tblfn1"><bold><italic><sup>a</sup></italic></bold></xref></th>
###xml 156 158 156 158 <bold xmlns:xlink="http://www.w3.org/1999/xlink">pT</bold>
###xml 156 158 156 158 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>pT</bold></th>
###xml 158 160 158 160 <bold xmlns:xlink="http://www.w3.org/1999/xlink">pN</bold>
###xml 158 160 158 160 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>pN</bold></th>
###xml 161 162 161 162 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 160 162 160 162 <bold xmlns:xlink="http://www.w3.org/1999/xlink">p<sc>m</sc></bold>
###xml 160 162 160 162 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>p<sc>m</sc></bold></th>
###xml 162 166 162 166 <bold xmlns:xlink="http://www.w3.org/1999/xlink">pTNM</bold>
###xml 162 166 162 166 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>pTNM</bold></th>
###xml 170 175 170 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 166 175 166 175 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MSP-<italic>RUNX3</italic></bold>
###xml 175 176 175 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 175 176 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>b</sup></italic>
###xml 175 176 175 176 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic><sup>b</sup></italic></bold>
###xml 175 176 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn2"><bold><italic><sup>b</sup></italic></bold></xref>
###xml 166 176 166 176 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>MSP-<italic>RUNX3</italic></bold><xref ref-type="table-fn" rid="tblfn2"><bold><italic><sup>b</sup></italic></bold></xref></th>
###xml 176 180 176 180 <bold xmlns:xlink="http://www.w3.org/1999/xlink">EZH2</bold>
###xml 180 181 180 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 180 181 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>c</sup></italic>
###xml 180 181 180 181 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic><sup>c</sup></italic></bold>
###xml 180 181 180 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><bold><italic><sup>c</sup></italic></bold></xref>
###xml 176 181 176 181 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>EZH2</bold><xref ref-type="table-fn" rid="tblfn3"><bold><italic><sup>c</sup></italic></bold></xref></th>
###xml 181 186 181 186 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</bold>
###xml 186 187 186 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 186 187 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>d</sup></italic>
###xml 186 187 186 187 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic><sup>d</sup></italic></bold>
###xml 186 187 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn4"><bold><italic><sup>d</sup></italic></bold></xref>
###xml 181 187 181 187 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>RUNX3</bold><xref ref-type="table-fn" rid="tblfn4"><bold><italic><sup>d</sup></italic></bold></xref></th>
###xml 187 205 187 205 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3-localization</bold>
###xml 205 206 205 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">e</sup>
###xml 205 206 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>e</sup></italic>
###xml 205 206 205 206 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic><sup>e</sup></italic></bold>
###xml 205 206 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn5"><bold><italic><sup>e</sup></italic></bold></xref>
###xml 187 206 187 206 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>RUNX3-localization</bold><xref ref-type="table-fn" rid="tblfn5"><bold><italic><sup>e</sup></italic></bold></xref></th>
###xml 129 206 129 206 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th colspan="1" rowspan="1" align="center" valign="top"><bold>Case No.</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Age</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Gender</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Histology</bold><xref ref-type="table-fn" rid="tblfn1"><bold><italic><sup>a</sup></italic></bold></xref></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>pT</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>pN</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>p<sc>m</sc></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>pTNM</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>MSP-<italic>RUNX3</italic></bold><xref ref-type="table-fn" rid="tblfn2"><bold><italic><sup>b</sup></italic></bold></xref></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>EZH2</bold><xref ref-type="table-fn" rid="tblfn3"><bold><italic><sup>c</sup></italic></bold></xref></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>RUNX3</bold><xref ref-type="table-fn" rid="tblfn4"><bold><italic><sup>d</sup></italic></bold></xref></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>RUNX3-localization</bold><xref ref-type="table-fn" rid="tblfn5"><bold><italic><sup>e</sup></italic></bold></xref></th></tr>
###xml 129 206 129 206 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Case No.</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Age</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Gender</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Histology</bold><xref ref-type="table-fn" rid="tblfn1"><bold><italic><sup>a</sup></italic></bold></xref></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>pT</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>pN</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>p<sc>m</sc></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>pTNM</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>MSP-<italic>RUNX3</italic></bold><xref ref-type="table-fn" rid="tblfn2"><bold><italic><sup>b</sup></italic></bold></xref></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>EZH2</bold><xref ref-type="table-fn" rid="tblfn3"><bold><italic><sup>c</sup></italic></bold></xref></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>RUNX3</bold><xref ref-type="table-fn" rid="tblfn4"><bold><italic><sup>d</sup></italic></bold></xref></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>RUNX3-localization</bold><xref ref-type="table-fn" rid="tblfn5"><bold><italic><sup>e</sup></italic></bold></xref></th></tr></thead>
###xml 206 209 206 209 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 1 </td>
###xml 209 213 209 213 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 61 </td>
###xml 213 216 213 216 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M </td>
###xml 216 221 216 221 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Sig </td>
###xml 221 225 221 225 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> T1 </td>
###xml 225 229 225 229 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> N0 </td>
###xml 229 233 229 233 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M0 </td>
###xml 233 237 233 237 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> IA </td>
###xml 237 249 237 249 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Methylated </td>
###xml 249 259 249 259 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Positive </td>
###xml 259 269 259 269 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Negative </td>
###xml 269 269 269 269 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 206 269 206 269 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 1 </td><td colspan="1" rowspan="1" align="center" valign="top"> 61 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Sig </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IA </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr>
###xml 269 272 269 272 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 2 </td>
###xml 272 276 272 276 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 52 </td>
###xml 276 279 276 279 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> F </td>
###xml 279 284 279 284 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Tub </td>
###xml 284 288 284 288 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> T3 </td>
###xml 288 292 288 292 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> N1 </td>
###xml 292 296 292 296 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M0 </td>
###xml 296 302 296 302 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> IIIA </td>
###xml 302 316 302 316 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td>
###xml 316 326 316 326 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Positive </td>
###xml 326 336 326 336 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Negative </td>
###xml 336 336 336 336 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 269 336 269 336 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 2 </td><td colspan="1" rowspan="1" align="center" valign="top"> 52 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T3 </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IIIA </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr>
###xml 336 339 336 339 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 3 </td>
###xml 339 343 339 343 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 74 </td>
###xml 343 346 343 346 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> F </td>
###xml 346 351 346 351 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Tub </td>
###xml 351 355 351 355 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> T3 </td>
###xml 355 359 355 359 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> N1 </td>
###xml 359 363 359 363 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M0 </td>
###xml 363 369 363 369 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> IIIA </td>
###xml 369 381 369 381 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Methylated </td>
###xml 381 391 381 391 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Positive </td>
###xml 391 401 391 401 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Negative </td>
###xml 401 401 401 401 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 336 401 336 401 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 3 </td><td colspan="1" rowspan="1" align="center" valign="top"> 74 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T3 </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IIIA </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr>
###xml 401 404 401 404 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 4 </td>
###xml 404 408 404 408 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 55 </td>
###xml 408 411 408 411 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> F </td>
###xml 411 416 411 416 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Por </td>
###xml 416 420 416 420 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> T3 </td>
###xml 420 424 420 424 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> N2 </td>
###xml 424 428 424 428 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M0 </td>
###xml 428 434 428 434 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> IIIB </td>
###xml 434 446 434 446 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Methylated </td>
###xml 446 456 446 456 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Positive </td>
###xml 456 466 456 466 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Negative </td>
###xml 466 466 466 466 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 401 466 401 466 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 4 </td><td colspan="1" rowspan="1" align="center" valign="top"> 55 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T3 </td><td colspan="1" rowspan="1" align="center" valign="top"> N2 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IIIB </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr>
###xml 466 469 466 469 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 5 </td>
###xml 469 473 469 473 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 57 </td>
###xml 473 476 473 476 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> F </td>
###xml 476 481 476 481 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Por </td>
###xml 481 485 481 485 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> T4 </td>
###xml 485 489 485 489 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> N1 </td>
###xml 489 493 489 493 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M0 </td>
###xml 493 497 493 497 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> IV </td>
###xml 497 511 497 511 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td>
###xml 511 521 511 521 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Positive </td>
###xml 521 531 521 531 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Negative </td>
###xml 531 531 531 531 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 466 531 466 531 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 5 </td><td colspan="1" rowspan="1" align="center" valign="top"> 57 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T4 </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IV </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr>
###xml 531 534 531 534 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 6 </td>
###xml 534 538 534 538 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 58 </td>
###xml 538 541 538 541 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M </td>
###xml 541 546 541 546 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Por </td>
###xml 546 550 546 550 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> T1 </td>
###xml 550 554 550 554 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> N1 </td>
###xml 554 558 554 558 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M0 </td>
###xml 558 562 558 562 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> IB </td>
###xml 562 576 562 576 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td>
###xml 576 586 576 586 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Positive </td>
###xml 586 596 586 596 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Negative </td>
###xml 596 596 596 596 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 531 596 531 596 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 6 </td><td colspan="1" rowspan="1" align="center" valign="top"> 58 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IB </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr>
###xml 596 599 596 599 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 7 </td>
###xml 599 603 599 603 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 75 </td>
###xml 603 606 603 606 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M </td>
###xml 606 611 606 611 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Tub </td>
###xml 611 615 611 615 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> T1 </td>
###xml 615 619 615 619 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> N0 </td>
###xml 619 623 619 623 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M0 </td>
###xml 623 627 623 627 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> IA </td>
###xml 627 639 627 639 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Methylated </td>
###xml 639 649 639 649 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Positive </td>
###xml 649 659 649 659 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Positive </td>
###xml 659 662 659 662 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> C </td>
###xml 596 662 596 662 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 7 </td><td colspan="1" rowspan="1" align="center" valign="top"> 75 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IA </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> C </td></tr>
###xml 662 665 662 665 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 8 </td>
###xml 665 669 665 669 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 54 </td>
###xml 669 672 669 672 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> F </td>
###xml 672 677 672 677 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Sig </td>
###xml 677 681 677 681 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> T1 </td>
###xml 681 685 681 685 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> N1 </td>
###xml 685 689 685 689 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M0 </td>
###xml 689 693 689 693 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> IB </td>
###xml 693 707 693 707 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td>
###xml 707 717 707 717 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Positive </td>
###xml 717 727 717 727 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Negative </td>
###xml 727 727 727 727 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 662 727 662 727 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 8 </td><td colspan="1" rowspan="1" align="center" valign="top"> 54 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Sig </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IB </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr>
###xml 727 730 727 730 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 9 </td>
###xml 730 734 730 734 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 65 </td>
###xml 734 737 734 737 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M </td>
###xml 737 742 737 742 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Sig </td>
###xml 742 747 742 747 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> T2a </td>
###xml 747 751 747 751 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> N0 </td>
###xml 751 755 751 755 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M0 </td>
###xml 755 759 755 759 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> IB </td>
###xml 759 771 759 771 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Methylated </td>
###xml 771 781 771 781 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Positive </td>
###xml 781 791 781 791 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Negative </td>
###xml 791 791 791 791 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 727 791 727 791 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 9 </td><td colspan="1" rowspan="1" align="center" valign="top"> 65 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Sig </td><td colspan="1" rowspan="1" align="center" valign="top"> T2a </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IB </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr>
###xml 791 795 791 795 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 10 </td>
###xml 795 799 795 799 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 77 </td>
###xml 799 802 799 802 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M </td>
###xml 802 807 802 807 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Tub </td>
###xml 807 812 807 812 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> T2a </td>
###xml 812 816 812 816 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> N1 </td>
###xml 816 820 816 820 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M0 </td>
###xml 820 824 820 824 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> II </td>
###xml 824 836 824 836 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Methylated </td>
###xml 836 846 836 846 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Positive </td>
###xml 846 856 846 856 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Negative </td>
###xml 856 856 856 856 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 791 856 791 856 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 10 </td><td colspan="1" rowspan="1" align="center" valign="top"> 77 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T2a </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> II </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr>
###xml 856 860 856 860 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 11 </td>
###xml 860 864 860 864 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 58 </td>
###xml 864 867 864 867 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> F </td>
###xml 867 872 867 872 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Tub </td>
###xml 872 876 872 876 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> T1 </td>
###xml 876 880 876 880 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> N0 </td>
###xml 880 884 880 884 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M0 </td>
###xml 884 888 884 888 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> IA </td>
###xml 888 902 888 902 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td>
###xml 902 912 902 912 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Positive </td>
###xml 912 922 912 922 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Positive </td>
###xml 922 925 922 925 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> C </td>
###xml 856 925 856 925 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 11 </td><td colspan="1" rowspan="1" align="center" valign="top"> 58 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IA </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> C </td></tr>
###xml 925 929 925 929 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 12 </td>
###xml 929 933 929 933 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 60 </td>
###xml 933 936 933 936 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M </td>
###xml 936 941 936 941 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Tub </td>
###xml 941 946 941 946 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> T2b </td>
###xml 946 950 946 950 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> N3 </td>
###xml 950 954 950 954 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M0 </td>
###xml 954 958 954 958 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> IV </td>
###xml 958 970 958 970 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Methylated </td>
###xml 970 980 970 980 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Positive </td>
###xml 980 990 980 990 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Negative </td>
###xml 990 990 990 990 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 925 990 925 990 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 12 </td><td colspan="1" rowspan="1" align="center" valign="top"> 60 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T2b </td><td colspan="1" rowspan="1" align="center" valign="top"> N3 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IV </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr>
###xml 990 994 990 994 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 13 </td>
###xml 994 998 994 998 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 66 </td>
###xml 998 1001 998 1001 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> F </td>
###xml 1001 1006 1001 1006 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Por </td>
###xml 1006 1011 1006 1011 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> T2b </td>
###xml 1011 1015 1011 1015 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> N1 </td>
###xml 1015 1019 1015 1019 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M0 </td>
###xml 1019 1023 1019 1023 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> II </td>
###xml 1023 1035 1023 1035 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Methylated </td>
###xml 1035 1045 1035 1045 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Negative </td>
###xml 1045 1055 1045 1055 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Positive </td>
###xml 1055 1064 1055 1064 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> N and C </td>
###xml 990 1064 990 1064 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 13 </td><td colspan="1" rowspan="1" align="center" valign="top"> 66 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T2b </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> II </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> N and C </td></tr>
###xml 1064 1068 1064 1068 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 14 </td>
###xml 1068 1072 1068 1072 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 68 </td>
###xml 1072 1075 1072 1075 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> F </td>
###xml 1075 1080 1075 1080 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Por </td>
###xml 1080 1085 1080 1085 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> T2b </td>
###xml 1085 1089 1085 1089 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> N0 </td>
###xml 1089 1093 1089 1093 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M0 </td>
###xml 1093 1097 1093 1097 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> IB </td>
###xml 1097 1109 1097 1109 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Methylated </td>
###xml 1109 1119 1109 1119 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Positive </td>
###xml 1119 1129 1119 1129 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Negative </td>
###xml 1129 1129 1129 1129 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 1064 1129 1064 1129 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 14 </td><td colspan="1" rowspan="1" align="center" valign="top"> 68 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T2b </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IB </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr>
###xml 1129 1133 1129 1133 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 15 </td>
###xml 1133 1137 1133 1137 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 66 </td>
###xml 1137 1140 1137 1140 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M </td>
###xml 1140 1145 1140 1145 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Tub </td>
###xml 1145 1149 1145 1149 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> T3 </td>
###xml 1149 1153 1149 1153 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> N2 </td>
###xml 1153 1157 1153 1157 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M0 </td>
###xml 1157 1163 1157 1163 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> IIIB </td>
###xml 1163 1177 1163 1177 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td>
###xml 1177 1187 1177 1187 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Negative </td>
###xml 1187 1197 1187 1197 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Positive </td>
###xml 1197 1206 1197 1206 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> N and C </td>
###xml 1129 1206 1129 1206 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 15 </td><td colspan="1" rowspan="1" align="center" valign="top"> 66 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T3 </td><td colspan="1" rowspan="1" align="center" valign="top"> N2 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IIIB </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> N and C </td></tr>
###xml 1206 1210 1206 1210 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 16 </td>
###xml 1210 1214 1210 1214 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 65 </td>
###xml 1214 1217 1214 1217 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> F </td>
###xml 1217 1222 1217 1222 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Tub </td>
###xml 1222 1227 1222 1227 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> T2b </td>
###xml 1227 1231 1227 1231 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> N2 </td>
###xml 1231 1235 1231 1235 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M0 </td>
###xml 1235 1241 1235 1241 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> IIIA </td>
###xml 1241 1253 1241 1253 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Methylated </td>
###xml 1253 1263 1253 1263 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Positive </td>
###xml 1263 1273 1263 1273 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Negative </td>
###xml 1273 1273 1273 1273 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 1206 1273 1206 1273 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 16 </td><td colspan="1" rowspan="1" align="center" valign="top"> 65 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T2b </td><td colspan="1" rowspan="1" align="center" valign="top"> N2 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IIIA </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr>
###xml 1273 1277 1273 1277 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 17 </td>
###xml 1277 1281 1277 1281 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 57 </td>
###xml 1281 1284 1281 1284 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M </td>
###xml 1284 1289 1284 1289 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Por </td>
###xml 1289 1293 1289 1293 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> T1 </td>
###xml 1293 1297 1293 1297 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> N0 </td>
###xml 1297 1301 1297 1301 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> M1 </td>
###xml 1301 1305 1301 1305 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> IV </td>
###xml 1305 1317 1305 1317 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Methylated </td>
###xml 1317 1327 1317 1327 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Negative </td>
###xml 1327 1337 1327 1337 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Positive </td>
###xml 1337 1340 1337 1340 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> C </td>
###xml 1273 1340 1273 1340 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 17 </td><td colspan="1" rowspan="1" align="center" valign="top"> 57 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M1 </td><td colspan="1" rowspan="1" align="center" valign="top"> IV </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> C </td></tr>
###xml 206 1340 206 1340 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="1" rowspan="1" align="left" valign="top"> 1 </td><td colspan="1" rowspan="1" align="center" valign="top"> 61 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Sig </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IA </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 2 </td><td colspan="1" rowspan="1" align="center" valign="top"> 52 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T3 </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IIIA </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 3 </td><td colspan="1" rowspan="1" align="center" valign="top"> 74 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T3 </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IIIA </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 4 </td><td colspan="1" rowspan="1" align="center" valign="top"> 55 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T3 </td><td colspan="1" rowspan="1" align="center" valign="top"> N2 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IIIB </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 5 </td><td colspan="1" rowspan="1" align="center" valign="top"> 57 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T4 </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IV </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 6 </td><td colspan="1" rowspan="1" align="center" valign="top"> 58 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IB </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 7 </td><td colspan="1" rowspan="1" align="center" valign="top"> 75 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IA </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> C </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 8 </td><td colspan="1" rowspan="1" align="center" valign="top"> 54 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Sig </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IB </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 9 </td><td colspan="1" rowspan="1" align="center" valign="top"> 65 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Sig </td><td colspan="1" rowspan="1" align="center" valign="top"> T2a </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IB </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 10 </td><td colspan="1" rowspan="1" align="center" valign="top"> 77 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T2a </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> II </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 11 </td><td colspan="1" rowspan="1" align="center" valign="top"> 58 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IA </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> C </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 12 </td><td colspan="1" rowspan="1" align="center" valign="top"> 60 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T2b </td><td colspan="1" rowspan="1" align="center" valign="top"> N3 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IV </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 13 </td><td colspan="1" rowspan="1" align="center" valign="top"> 66 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T2b </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> II </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> N and C </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 14 </td><td colspan="1" rowspan="1" align="center" valign="top"> 68 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T2b </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IB </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 15 </td><td colspan="1" rowspan="1" align="center" valign="top"> 66 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T3 </td><td colspan="1" rowspan="1" align="center" valign="top"> N2 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IIIB </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> N and C </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 16 </td><td colspan="1" rowspan="1" align="center" valign="top"> 65 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T2b </td><td colspan="1" rowspan="1" align="center" valign="top"> N2 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IIIA </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 17 </td><td colspan="1" rowspan="1" align="center" valign="top"> 57 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M1 </td><td colspan="1" rowspan="1" align="center" valign="top"> IV </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> C </td></tr></tbody>
###xml 129 1340 129 1340 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Case No.</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Age</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Gender</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Histology</bold><xref ref-type="table-fn" rid="tblfn1"><bold><italic><sup>a</sup></italic></bold></xref></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>pT</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>pN</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>p<sc>m</sc></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>pTNM</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>MSP-<italic>RUNX3</italic></bold><xref ref-type="table-fn" rid="tblfn2"><bold><italic><sup>b</sup></italic></bold></xref></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>EZH2</bold><xref ref-type="table-fn" rid="tblfn3"><bold><italic><sup>c</sup></italic></bold></xref></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>RUNX3</bold><xref ref-type="table-fn" rid="tblfn4"><bold><italic><sup>d</sup></italic></bold></xref></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>RUNX3-localization</bold><xref ref-type="table-fn" rid="tblfn5"><bold><italic><sup>e</sup></italic></bold></xref></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"> 1 </td><td colspan="1" rowspan="1" align="center" valign="top"> 61 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Sig </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IA </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 2 </td><td colspan="1" rowspan="1" align="center" valign="top"> 52 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T3 </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IIIA </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 3 </td><td colspan="1" rowspan="1" align="center" valign="top"> 74 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T3 </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IIIA </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 4 </td><td colspan="1" rowspan="1" align="center" valign="top"> 55 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T3 </td><td colspan="1" rowspan="1" align="center" valign="top"> N2 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IIIB </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 5 </td><td colspan="1" rowspan="1" align="center" valign="top"> 57 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T4 </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IV </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 6 </td><td colspan="1" rowspan="1" align="center" valign="top"> 58 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IB </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 7 </td><td colspan="1" rowspan="1" align="center" valign="top"> 75 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IA </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> C </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 8 </td><td colspan="1" rowspan="1" align="center" valign="top"> 54 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Sig </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IB </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 9 </td><td colspan="1" rowspan="1" align="center" valign="top"> 65 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Sig </td><td colspan="1" rowspan="1" align="center" valign="top"> T2a </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IB </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 10 </td><td colspan="1" rowspan="1" align="center" valign="top"> 77 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T2a </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> II </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 11 </td><td colspan="1" rowspan="1" align="center" valign="top"> 58 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IA </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> C </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 12 </td><td colspan="1" rowspan="1" align="center" valign="top"> 60 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T2b </td><td colspan="1" rowspan="1" align="center" valign="top"> N3 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IV </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 13 </td><td colspan="1" rowspan="1" align="center" valign="top"> 66 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T2b </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> II </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> N and C </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 14 </td><td colspan="1" rowspan="1" align="center" valign="top"> 68 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T2b </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IB </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 15 </td><td colspan="1" rowspan="1" align="center" valign="top"> 66 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T3 </td><td colspan="1" rowspan="1" align="center" valign="top"> N2 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IIIB </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> N and C </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 16 </td><td colspan="1" rowspan="1" align="center" valign="top"> 65 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T2b </td><td colspan="1" rowspan="1" align="center" valign="top"> N2 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IIIA </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 17 </td><td colspan="1" rowspan="1" align="center" valign="top"> 57 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M1 </td><td colspan="1" rowspan="1" align="center" valign="top"> IV </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> C </td></tr></tbody></table>
###xml 1340 1341 1340 1341 <label xmlns:xlink="http://www.w3.org/1999/xlink">a</label>
###xml 1341 1455 1341 1455 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="42">Histology: sig, signet-ring cell carcinoma; tub, tubular adenocarcinoma; por, poorly differentiated adenocarcinoma</p>
###xml 1340 1455 1340 1455 <fn xmlns:xlink="http://www.w3.org/1999/xlink" id="tblfn1"><label>a</label><p textid="42">Histology: sig, signet-ring cell carcinoma; tub, tubular adenocarcinoma; por, poorly differentiated adenocarcinoma</p></fn>
###xml 1455 1456 1455 1456 <label xmlns:xlink="http://www.w3.org/1999/xlink">b</label>
###xml 1478 1483 1478 1483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 1456 1517 1456 1517 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="43">Methylation status of <italic>RUNX3</italic> by methylation-specific PCR (MSP)</p>
###xml 1455 1517 1455 1517 <fn xmlns:xlink="http://www.w3.org/1999/xlink" id="tblfn2"><label>b</label><p textid="43">Methylation status of <italic>RUNX3</italic> by methylation-specific PCR (MSP)</p></fn>
###xml 1517 1518 1517 1518 <label xmlns:xlink="http://www.w3.org/1999/xlink">c</label>
###xml 1518 1583 1518 1583 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="44">EZH2 overexpression was evaluated by immunohistochemical staining</p>
###xml 1517 1583 1517 1583 <fn xmlns:xlink="http://www.w3.org/1999/xlink" id="tblfn3"><label>c</label><p textid="44">EZH2 overexpression was evaluated by immunohistochemical staining</p></fn>
###xml 1583 1584 1583 1584 <label xmlns:xlink="http://www.w3.org/1999/xlink">d</label>
###xml 1584 1646 1584 1646 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="45">RUNX3 expression was evaluated by immunohistochemical staining</p>
###xml 1583 1646 1583 1646 <fn xmlns:xlink="http://www.w3.org/1999/xlink" id="tblfn4"><label>d</label><p textid="45">RUNX3 expression was evaluated by immunohistochemical staining</p></fn>
###xml 1646 1647 1646 1647 <label xmlns:xlink="http://www.w3.org/1999/xlink">e</label>
###xml 1647 1710 1647 1710 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="46">RUNX3 protein was localized in nucleus (N) or/and cytoplasm (C)</p>
###xml 1646 1710 1646 1710 <fn xmlns:xlink="http://www.w3.org/1999/xlink" id="tblfn5"><label>e</label><p textid="46">RUNX3 protein was localized in nucleus (N) or/and cytoplasm (C)</p></fn>
###xml 1340 1710 1340 1710 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><fn id="tblfn1"><label>a</label><p textid="42">Histology: sig, signet-ring cell carcinoma; tub, tubular adenocarcinoma; por, poorly differentiated adenocarcinoma</p></fn><fn id="tblfn2"><label>b</label><p textid="43">Methylation status of <italic>RUNX3</italic> by methylation-specific PCR (MSP)</p></fn><fn id="tblfn3"><label>c</label><p textid="44">EZH2 overexpression was evaluated by immunohistochemical staining</p></fn><fn id="tblfn4"><label>d</label><p textid="45">RUNX3 expression was evaluated by immunohistochemical staining</p></fn><fn id="tblfn5"><label>e</label><p textid="46">RUNX3 protein was localized in nucleus (N) or/and cytoplasm (C)</p></fn></table-wrap-foot>
###xml 0 1710 0 1710 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="tbl1"><label>TABLE 1</label><caption><p textid="41"><bold>Relationship between <italic>RUNX3</italic> methylation, overexpression of EZH2 protein, and loss of RUNX3 protein in gastric cancer tissue</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Case No.</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Age</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Gender</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Histology</bold><xref ref-type="table-fn" rid="tblfn1"><bold><italic><sup>a</sup></italic></bold></xref></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>pT</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>pN</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>p<sc>m</sc></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>pTNM</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>MSP-<italic>RUNX3</italic></bold><xref ref-type="table-fn" rid="tblfn2"><bold><italic><sup>b</sup></italic></bold></xref></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>EZH2</bold><xref ref-type="table-fn" rid="tblfn3"><bold><italic><sup>c</sup></italic></bold></xref></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>RUNX3</bold><xref ref-type="table-fn" rid="tblfn4"><bold><italic><sup>d</sup></italic></bold></xref></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>RUNX3-localization</bold><xref ref-type="table-fn" rid="tblfn5"><bold><italic><sup>e</sup></italic></bold></xref></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"> 1 </td><td colspan="1" rowspan="1" align="center" valign="top"> 61 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Sig </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IA </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 2 </td><td colspan="1" rowspan="1" align="center" valign="top"> 52 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T3 </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IIIA </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 3 </td><td colspan="1" rowspan="1" align="center" valign="top"> 74 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T3 </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IIIA </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 4 </td><td colspan="1" rowspan="1" align="center" valign="top"> 55 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T3 </td><td colspan="1" rowspan="1" align="center" valign="top"> N2 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IIIB </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 5 </td><td colspan="1" rowspan="1" align="center" valign="top"> 57 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T4 </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IV </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 6 </td><td colspan="1" rowspan="1" align="center" valign="top"> 58 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IB </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 7 </td><td colspan="1" rowspan="1" align="center" valign="top"> 75 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IA </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> C </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 8 </td><td colspan="1" rowspan="1" align="center" valign="top"> 54 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Sig </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IB </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 9 </td><td colspan="1" rowspan="1" align="center" valign="top"> 65 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Sig </td><td colspan="1" rowspan="1" align="center" valign="top"> T2a </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IB </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 10 </td><td colspan="1" rowspan="1" align="center" valign="top"> 77 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T2a </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> II </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 11 </td><td colspan="1" rowspan="1" align="center" valign="top"> 58 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IA </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> C </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 12 </td><td colspan="1" rowspan="1" align="center" valign="top"> 60 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T2b </td><td colspan="1" rowspan="1" align="center" valign="top"> N3 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IV </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 13 </td><td colspan="1" rowspan="1" align="center" valign="top"> 66 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T2b </td><td colspan="1" rowspan="1" align="center" valign="top"> N1 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> II </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> N and C </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 14 </td><td colspan="1" rowspan="1" align="center" valign="top"> 68 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T2b </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IB </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 15 </td><td colspan="1" rowspan="1" align="center" valign="top"> 66 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T3 </td><td colspan="1" rowspan="1" align="center" valign="top"> N2 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IIIB </td><td colspan="1" rowspan="1" align="center" valign="top"> Unmethylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> N and C </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 16 </td><td colspan="1" rowspan="1" align="center" valign="top"> 65 </td><td colspan="1" rowspan="1" align="center" valign="top"> F </td><td colspan="1" rowspan="1" align="center" valign="top"> Tub </td><td colspan="1" rowspan="1" align="center" valign="top"> T2b </td><td colspan="1" rowspan="1" align="center" valign="top"> N2 </td><td colspan="1" rowspan="1" align="center" valign="top"> M0 </td><td colspan="1" rowspan="1" align="center" valign="top"> IIIA </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 17 </td><td colspan="1" rowspan="1" align="center" valign="top"> 57 </td><td colspan="1" rowspan="1" align="center" valign="top"> M </td><td colspan="1" rowspan="1" align="center" valign="top"> Por </td><td colspan="1" rowspan="1" align="center" valign="top"> T1 </td><td colspan="1" rowspan="1" align="center" valign="top"> N0 </td><td colspan="1" rowspan="1" align="center" valign="top"> M1 </td><td colspan="1" rowspan="1" align="center" valign="top"> IV </td><td colspan="1" rowspan="1" align="center" valign="top"> Methylated </td><td colspan="1" rowspan="1" align="center" valign="top"> Negative </td><td colspan="1" rowspan="1" align="center" valign="top"> Positive </td><td colspan="1" rowspan="1" align="center" valign="top"> C </td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><label>a</label><p textid="42">Histology: sig, signet-ring cell carcinoma; tub, tubular adenocarcinoma; por, poorly differentiated adenocarcinoma</p></fn><fn id="tblfn2"><label>b</label><p textid="43">Methylation status of <italic>RUNX3</italic> by methylation-specific PCR (MSP)</p></fn><fn id="tblfn3"><label>c</label><p textid="44">EZH2 overexpression was evaluated by immunohistochemical staining</p></fn><fn id="tblfn4"><label>d</label><p textid="45">RUNX3 expression was evaluated by immunohistochemical staining</p></fn><fn id="tblfn5"><label>e</label><p textid="46">RUNX3 protein was localized in nucleus (N) or/and cytoplasm (C)</p></fn></table-wrap-foot></table-wrap>
TABLE 1Relationship between RUNX3 methylation, overexpression of EZH2 protein, and loss of RUNX3 protein in gastric cancer tissueCase No.AgeGenderHistologyapTpNpmpTNMMSP-RUNX3bEZH2cRUNX3dRUNX3-localizatione 1  61  M  Sig  T1  N0  M0  IA  Methylated  Positive  Negative  2  52  F  Tub  T3  N1  M0  IIIA  Unmethylated  Positive  Negative  3  74  F  Tub  T3  N1  M0  IIIA  Methylated  Positive  Negative  4  55  F  Por  T3  N2  M0  IIIB  Methylated  Positive  Negative  5  57  F  Por  T4  N1  M0  IV  Unmethylated  Positive  Negative  6  58  M  Por  T1  N1  M0  IB  Unmethylated  Positive  Negative  7  75  M  Tub  T1  N0  M0  IA  Methylated  Positive  Positive  C  8  54  F  Sig  T1  N1  M0  IB  Unmethylated  Positive  Negative  9  65  M  Sig  T2a  N0  M0  IB  Methylated  Positive  Negative  10  77  M  Tub  T2a  N1  M0  II  Methylated  Positive  Negative  11  58  F  Tub  T1  N0  M0  IA  Unmethylated  Positive  Positive  C  12  60  M  Tub  T2b  N3  M0  IV  Methylated  Positive  Negative  13  66  F  Por  T2b  N1  M0  II  Methylated  Negative  Positive  N and C  14  68  F  Por  T2b  N0  M0  IB  Methylated  Positive  Negative  15  66  M  Tub  T3  N2  M0  IIIB  Unmethylated  Negative  Positive  N and C  16  65  F  Tub  T2b  N2  M0  IIIA  Methylated  Positive  Negative  17  57  M  Por  T1  N0  M1  IV  Methylated  Negative  Positive  C aHistology: sig, signet-ring cell carcinoma; tub, tubular adenocarcinoma; por, poorly differentiated adenocarcinomabMethylation status of RUNX3 by methylation-specific PCR (MSP)cEZH2 overexpression was evaluated by immunohistochemical stainingdRUNX3 expression was evaluated by immunohistochemical stainingeRUNX3 protein was localized in nucleus (N) or/and cytoplasm (C)
###end p 40
###begin p 41
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 0 122 0 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Relationship between <italic>RUNX3</italic> methylation, overexpression of EZH2 protein, and loss of RUNX3 protein in gastric cancer tissue</bold>
Relationship between RUNX3 methylation, overexpression of EZH2 protein, and loss of RUNX3 protein in gastric cancer tissue
###end p 41
###begin p 42
Histology: sig, signet-ring cell carcinoma; tub, tubular adenocarcinoma; por, poorly differentiated adenocarcinoma
###end p 42
###begin p 43
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
Methylation status of RUNX3 by methylation-specific PCR (MSP)
###end p 43
###begin p 44
EZH2 overexpression was evaluated by immunohistochemical staining
###end p 44
###begin p 45
RUNX3 expression was evaluated by immunohistochemical staining
###end p 45
###begin p 46
RUNX3 protein was localized in nucleus (N) or/and cytoplasm (C)
###end p 46
###begin p 47
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 5.</label>
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 9 182 9 182 <bold xmlns:xlink="http://www.w3.org/1999/xlink">DNA methylation of the <italic>RUNX3</italic> promoter, and expression of EZH2 protein and RUNX3 protein detected by immunohistochemical staining in tissue specimens from 17 gastric cancers.</bold>
###xml 182 183 182 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 350 351 350 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 374 375 374 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">U</italic>
###xml 458 459 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 452 459 452 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 465 477 465 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper number</italic>
###xml 498 499 498 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 523 524 523 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 540 542 540 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ma</italic>
###xml 580 581 580 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 586 587 586 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 755 756 755 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 765 766 765 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1026 1038 1026 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink">square boxes</italic>
###xml 1156 1157 1156 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1309 1310 1309 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1352 1357 1352 1357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 1397 1398 1397 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1481 1482 1481 1482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1627 1628 1627 1628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 9 1630 9 1630 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="48"><bold>DNA methylation of the <italic>RUNX3</italic> promoter, and expression of EZH2 protein and RUNX3 protein detected by immunohistochemical staining in tissue specimens from 17 gastric cancers.</bold><italic>A</italic>, DNA methylation of the <italic>RUNX3</italic> promoter was detected by MSP analysis in 11 of the 17 specimens (64.7%). Primer sets that specifically amplified either methylated DNA (<italic>M</italic>) or unmethylated DNA (<italic>U</italic>) were the same as used in the MSP analysis of the five cancer cell lines in <xref rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>. The <italic>upper number</italic> is the case number. <italic>N</italic>, non-cancerous tissue; <italic>T</italic>, tumor tissue. <italic>Ma</italic>, 200- and 300-bp DNA ladder markers. <italic>B</italic> and <italic>C</italic>, histological appearance of the gastric cancer stained with H&amp;E (hematoxylin and eosin) and immunohistochemically for EZH2 and RUNX3. The representative cases are 13 (<italic>B</italic>) and 2 (<italic>C</italic>). Immunohistochemical stainings for EZH2 and RUNX3 proteins were performed using two continuous thin tissue sections to show the inverse correlation of expression of EZH2 and RUNX3 proteins in individual cancer cells. The areas of cancer tissue surrounded by <italic>square boxes</italic> were magnified to show the expression or repression of EZH2 protein and RUNX3 protein of individual cancer cells. In <italic>B</italic> (case number 13), EZH2 is normally expressed in the germinal center follicular lymphocytes, whereas RUNX3 is normally expressed in the lymphocytes. In <italic>B</italic> (case number 13), DNA methylation in the <italic>RUNX3</italic> promoter was detected in MSP analysis (<italic>A</italic>), but RUNX3 expression is observed in gastric cancer cells. On the other hand, in <italic>C</italic> (case number 2), loss of RUNX3 is observed in gastric cancer cells, but no DNA methylation of the promoter region was detected in MSP analysis (<italic>A</italic>).</p>
###xml 9 1630 9 1630 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="48"><bold>DNA methylation of the <italic>RUNX3</italic> promoter, and expression of EZH2 protein and RUNX3 protein detected by immunohistochemical staining in tissue specimens from 17 gastric cancers.</bold><italic>A</italic>, DNA methylation of the <italic>RUNX3</italic> promoter was detected by MSP analysis in 11 of the 17 specimens (64.7%). Primer sets that specifically amplified either methylated DNA (<italic>M</italic>) or unmethylated DNA (<italic>U</italic>) were the same as used in the MSP analysis of the five cancer cell lines in <xref rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>. The <italic>upper number</italic> is the case number. <italic>N</italic>, non-cancerous tissue; <italic>T</italic>, tumor tissue. <italic>Ma</italic>, 200- and 300-bp DNA ladder markers. <italic>B</italic> and <italic>C</italic>, histological appearance of the gastric cancer stained with H&amp;E (hematoxylin and eosin) and immunohistochemically for EZH2 and RUNX3. The representative cases are 13 (<italic>B</italic>) and 2 (<italic>C</italic>). Immunohistochemical stainings for EZH2 and RUNX3 proteins were performed using two continuous thin tissue sections to show the inverse correlation of expression of EZH2 and RUNX3 proteins in individual cancer cells. The areas of cancer tissue surrounded by <italic>square boxes</italic> were magnified to show the expression or repression of EZH2 protein and RUNX3 protein of individual cancer cells. In <italic>B</italic> (case number 13), EZH2 is normally expressed in the germinal center follicular lymphocytes, whereas RUNX3 is normally expressed in the lymphocytes. In <italic>B</italic> (case number 13), DNA methylation in the <italic>RUNX3</italic> promoter was detected in MSP analysis (<italic>A</italic>), but RUNX3 expression is observed in gastric cancer cells. On the other hand, in <italic>C</italic> (case number 2), loss of RUNX3 is observed in gastric cancer cells, but no DNA methylation of the promoter region was detected in MSP analysis (<italic>A</italic>).</p></caption>
###xml 1630 1630 1630 1630 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0280841070005"/>
###xml 0 1630 0 1630 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig5"><label>FIGURE 5.</label><caption><p textid="48"><bold>DNA methylation of the <italic>RUNX3</italic> promoter, and expression of EZH2 protein and RUNX3 protein detected by immunohistochemical staining in tissue specimens from 17 gastric cancers.</bold><italic>A</italic>, DNA methylation of the <italic>RUNX3</italic> promoter was detected by MSP analysis in 11 of the 17 specimens (64.7%). Primer sets that specifically amplified either methylated DNA (<italic>M</italic>) or unmethylated DNA (<italic>U</italic>) were the same as used in the MSP analysis of the five cancer cell lines in <xref rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>. The <italic>upper number</italic> is the case number. <italic>N</italic>, non-cancerous tissue; <italic>T</italic>, tumor tissue. <italic>Ma</italic>, 200- and 300-bp DNA ladder markers. <italic>B</italic> and <italic>C</italic>, histological appearance of the gastric cancer stained with H&amp;E (hematoxylin and eosin) and immunohistochemically for EZH2 and RUNX3. The representative cases are 13 (<italic>B</italic>) and 2 (<italic>C</italic>). Immunohistochemical stainings for EZH2 and RUNX3 proteins were performed using two continuous thin tissue sections to show the inverse correlation of expression of EZH2 and RUNX3 proteins in individual cancer cells. The areas of cancer tissue surrounded by <italic>square boxes</italic> were magnified to show the expression or repression of EZH2 protein and RUNX3 protein of individual cancer cells. In <italic>B</italic> (case number 13), EZH2 is normally expressed in the germinal center follicular lymphocytes, whereas RUNX3 is normally expressed in the lymphocytes. In <italic>B</italic> (case number 13), DNA methylation in the <italic>RUNX3</italic> promoter was detected in MSP analysis (<italic>A</italic>), but RUNX3 expression is observed in gastric cancer cells. On the other hand, in <italic>C</italic> (case number 2), loss of RUNX3 is observed in gastric cancer cells, but no DNA methylation of the promoter region was detected in MSP analysis (<italic>A</italic>).</p></caption><graphic xlink:href="zbc0280841070005"/></fig>
FIGURE 5.DNA methylation of the RUNX3 promoter, and expression of EZH2 protein and RUNX3 protein detected by immunohistochemical staining in tissue specimens from 17 gastric cancers.A, DNA methylation of the RUNX3 promoter was detected by MSP analysis in 11 of the 17 specimens (64.7%). Primer sets that specifically amplified either methylated DNA (M) or unmethylated DNA (U) were the same as used in the MSP analysis of the five cancer cell lines in Fig. 2B. The upper number is the case number. N, non-cancerous tissue; T, tumor tissue. Ma, 200- and 300-bp DNA ladder markers. B and C, histological appearance of the gastric cancer stained with H&E (hematoxylin and eosin) and immunohistochemically for EZH2 and RUNX3. The representative cases are 13 (B) and 2 (C). Immunohistochemical stainings for EZH2 and RUNX3 proteins were performed using two continuous thin tissue sections to show the inverse correlation of expression of EZH2 and RUNX3 proteins in individual cancer cells. The areas of cancer tissue surrounded by square boxes were magnified to show the expression or repression of EZH2 protein and RUNX3 protein of individual cancer cells. In B (case number 13), EZH2 is normally expressed in the germinal center follicular lymphocytes, whereas RUNX3 is normally expressed in the lymphocytes. In B (case number 13), DNA methylation in the RUNX3 promoter was detected in MSP analysis (A), but RUNX3 expression is observed in gastric cancer cells. On the other hand, in C (case number 2), loss of RUNX3 is observed in gastric cancer cells, but no DNA methylation of the promoter region was detected in MSP analysis (A).
###end p 47
###begin p 48
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 0 173 0 173 <bold xmlns:xlink="http://www.w3.org/1999/xlink">DNA methylation of the <italic>RUNX3</italic> promoter, and expression of EZH2 protein and RUNX3 protein detected by immunohistochemical staining in tissue specimens from 17 gastric cancers.</bold>
###xml 173 174 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 199 204 199 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 341 342 341 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 365 366 365 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">U</italic>
###xml 449 450 449 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 443 450 443 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 456 468 456 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper number</italic>
###xml 489 490 489 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 514 515 514 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 531 533 531 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ma</italic>
###xml 571 572 571 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 577 578 577 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 746 747 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 756 757 756 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1017 1029 1017 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink">square boxes</italic>
###xml 1147 1148 1147 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1300 1301 1300 1301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1343 1348 1343 1348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 1388 1389 1388 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1472 1473 1472 1473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1618 1619 1618 1619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
DNA methylation of the RUNX3 promoter, and expression of EZH2 protein and RUNX3 protein detected by immunohistochemical staining in tissue specimens from 17 gastric cancers.A, DNA methylation of the RUNX3 promoter was detected by MSP analysis in 11 of the 17 specimens (64.7%). Primer sets that specifically amplified either methylated DNA (M) or unmethylated DNA (U) were the same as used in the MSP analysis of the five cancer cell lines in Fig. 2B. The upper number is the case number. N, non-cancerous tissue; T, tumor tissue. Ma, 200- and 300-bp DNA ladder markers. B and C, histological appearance of the gastric cancer stained with H&E (hematoxylin and eosin) and immunohistochemically for EZH2 and RUNX3. The representative cases are 13 (B) and 2 (C). Immunohistochemical stainings for EZH2 and RUNX3 proteins were performed using two continuous thin tissue sections to show the inverse correlation of expression of EZH2 and RUNX3 proteins in individual cancer cells. The areas of cancer tissue surrounded by square boxes were magnified to show the expression or repression of EZH2 protein and RUNX3 protein of individual cancer cells. In B (case number 13), EZH2 is normally expressed in the germinal center follicular lymphocytes, whereas RUNX3 is normally expressed in the lymphocytes. In B (case number 13), DNA methylation in the RUNX3 promoter was detected in MSP analysis (A), but RUNX3 expression is observed in gastric cancer cells. On the other hand, in C (case number 2), loss of RUNX3 is observed in gastric cancer cells, but no DNA methylation of the promoter region was detected in MSP analysis (A).
###end p 48
###begin title 49
DISCUSSION
###end title 49
###begin p 50
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 452 457 452 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
The Polycomb group (PcG) protein EZH2, a histone methyltransferase and component of the PRC2 complex, is the product of a well known oncogene and a marker of poor prognosis in various cancers, including prostate cancer and breast cancer (18, 19). The mechanism underlying EZH2 overexpression associated with poor prognosis and the target genes down-regulated by EZH2, which lead to oncogenic activity, are still unknown. The mechanism of regulation of RUNX3 by EZH2 reported above may shed some light on the mechanism underlying EZH2 overexpression.
###end p 50
###begin p 51
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref30">30</xref>
###xml 331 336 331 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 531 534 531 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;E</italic>
###xml 523 534 523 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, <italic>A&#8211;E</italic></xref>
###xml 636 641 636 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 829 834 829 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 914 915 914 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 908 915 908 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 1126 1131 1126 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 1155 1160 1155 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 1192 1193 1192 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1186 1193 1186 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 1234 1239 1234 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 1500 1502 1500 1502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
###xml 1604 1609 1604 1609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
Polycomb target genes are often silenced by histone deacetylation and DNA methylation of CpG islands (30), and this is explained by the ability of PcG proteins to bind histone deacetylases and recruit DNA methyltransferases. We used TSA, a cell permeable inhibitor of histone deacetylases, to investigate whether expression of the RUNX3 gene is also controlled by histone deacetylation, and exposure of the five cancer cell lines to TSA for 48 h actually resulted in a 2.5-26.2-fold increase in the RUNX3 transcript level (Fig. 3, A-E). Because TSA did not affect the expression level of EZH2, these findings strongly indicate that the RUNX3 gene is also silenced by histone deacetylation. To test in detail, we performed ChIP experiments with antibodies against HDAC1. After transfection with control siRNA, both regions of the RUNX3 promoter examined were bound to HDAC1 in the MKN28 and MCF-7 cell lines (Fig. 2A), both of whose Runx3 transcript levels were restored only by TSA treatment for 48 h. By contrast, after transfection of these two cancer cell lines with EZH2 siRNA, less HDAC1 was bound to both regions of the RUNX3 promoter examined when RUNX3 expression was restored (Fig. 2A). This suggests that down-regulation of RUNX3 may be mediated by both H3K27 trimethylation by EZH2 and histone deacetylation by HDAC1. A previous study also showed restoration of both RUNX3 transcript and RUNX3 protein levels in breast cancer cell lines including MCF-7, T47D, and MDA-MB-231 by TSA alone (27). Moreover, the results of our study showed that EZH2 and HDAC1 act synergistically to down-regulate RUNX3 expression.
###end p 51
###begin p 52
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 315 318 315 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;E</italic>
###xml 307 318 307 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, <italic>A&#8211;E</italic></xref>
###xml 391 396 391 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 529 534 529 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 711 714 711 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;E</italic>
###xml 703 714 703 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, <italic>A&#8211;E</italic></xref>
###xml 884 889 884 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 913 914 913 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 907 914 907 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 1013 1018 1013 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
Hypermethylation of RUNX3 had been found to be common in many types of cancer cell lines and to correlate with loss of RUNX3 expression, and in the present study we found that 5-aza-dC, an inhibitor of DNA methyltransferase, promoted expression of the RUNX3 gene in five cancer cell lines by 1.5-10.9-fold (Fig. 3, A-E), indicating that DNA methylation also contributed to the repression of RUNX3. A comparison between DNA methylation and HDAC1 binding (histone deacetylation) to determine which was more effective in repressing RUNX3 showed that the level of RUNX3 transcript restoration by TSA was much greater than by 5-aza-dC in four of the cancer cell lines, the exception being the MiaPaca2 line (Fig. 3, A-E). In our study, EZH2 knockdown by transient siRNA transfection restored the RUNX3 transcript level 3.5-10.4-fold without any change in the DNA methylation status of the RUNX3 promoter region (Fig. 1A). This finding indicates that histone modification by EZH2 plays a key role in down-regulation of RUNX3, in addition to DNA methylation in the promoter.
###end p 52
###begin p 53
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 298 299 298 299 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 417 418 417 418 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 785 787 785 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 803 808 803 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 822 825 822 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p21</italic>
###xml 825 834 825 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WAF1/Cip1</sup>
###xml 918 920 918 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 964 969 964 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 358 363 <span type="species:ncbi:10090">mouse</span>
###xml 583 588 <span type="species:ncbi:9606">human</span>
EZH2 expression has been proposed as a marker of invasion and aggressive tumors (18, 19, 31), and experimental data have indicated a role of EZH2 in cell cycle regulation and proliferation. For example, disruption of EZH2 expression retards cell proliferation and induces cell cycle arrest at the G2-M transition (16), and overexpression of EZH2 in cultured mouse embryonic fibroblasts has been found to shorten the G1 phase of the cell cycle and lead to accumulation of cells in the S phase (17). A significant association between EZH2 and tumor cell proliferation, as estimated in human tumor tissue by Ki-67 expression and mitotic count, was recently demonstrated in clinical specimens including specimens of cutaneous melanoma and cancers of the endometrium, prostate, and breast (32). By contrast, RUNX3 up-regulates p21WAF1/Cip1, an important factor in cyclin-dependent kinase inhibition and cell cycle control (21). It was suggested that down-regulation of RUNX3 by EZH2 overexpression shown in the present study may be one pathway by which EZH2 affects tumor cell proliferation.
###end p 53
###begin p 54
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 138 143 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 195 200 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
###xml 517 522 517 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3</italic>
In summary, in this study, we showed that increased expression of EZH2 results in H3K27 trimethylation of the RUNX3 gene, indicating that RUNX3 is a novel EZH2 target gene. The identification of RUNX3 as an EZH2 target gene can support an influence of EZH2 overexpression on increasing tumor cell proliferation. Our findings suggest that specific inhibitors of EZH2 may be useful in the treatment of several types of cancers because such inhibitors are expected to reverse the down-regulation of the tumor suppressor RUNX3.
###end p 54
###begin title 55
Supplementary Material
###end title 55
###begin title 56
[Supplemental Data]
###end title 56
###begin title 57
[Supplemental Data]
###end title 57
###begin p 58
We thank Mai Okumoto for technical assistance.
###end p 58
###begin p 59
The abbreviations used are: EZH2, enhancer of zeste homologue 2; siRNA, small interfering RNA; RT, reverse transcriptase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; ChIP, chromatin immunoprecipitation; MYT1, myelin transcription factor 1; MSP, methylation-specific polymerase chain reaction; TSA, trichostatin A; 5-aza-dC, 5-aza-2'-deoxycytidine; HDAC1, histone deacetylase 1.
###end p 59

